{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:18:24Z","timestamp":1790194704984,"version":"4.1.0"},"reference-count":379,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41568-026-00952-w","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:09:27Z","timestamp":1782922167000},"page":"790-817","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Systemic health impact of cancer-associated extracellular vesicles and particles"],"prefix":"10.1038","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0297-6467","authenticated-orcid":false,"given":"Gang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Lucotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2684-5824","authenticated-orcid":false,"given":"Linda","family":"Bojmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel C.","family":"Tobias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1250-683X","authenticated-orcid":false,"given":"Richard T.","family":"Piszczatowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shani","family":"Dror","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0193-4131","authenticated-orcid":false,"given":"David","family":"Lyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"952_CR1","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41568-024-00708-4","volume":"24","author":"A Boire","year":"2024","unstructured":"Boire, A. et al. Why do patients with cancer die? Nat. Rev. Cancer 24, 578\u2013589 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"952_CR2","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41568-020-0251-4","volume":"20","author":"AK Biswas","year":"2020","unstructured":"Biswas, A. K. & Acharyya, S. Understanding cachexia in the context of metastatic progression. Nat. Rev. Cancer 20, 274\u2013284 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"952_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41556-021-00635-8","volume":"23","author":"G Wang","year":"2021","unstructured":"Wang, G., Zhang, H. & Lyden, D. Tumour-regulated anorexia preceding cachexia. Nat. Cell Biol. 23, 111\u2013113 (2021).","journal-title":"Nat. Cell Biol."},{"key":"952_CR4","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021109288","volume":"41","author":"S Lucotti","year":"2022","unstructured":"Lucotti, S., Kenific, C. M., Zhang, H. & Lyden, D. Extracellular vesicles and particles impact the systemic landscape of cancer. EMBO J. 41, e109288 (2022).","journal-title":"EMBO J."},{"key":"952_CR5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41580-022-00460-3","volume":"23","author":"G van Niel","year":"2022","unstructured":"van Niel, G. et al. Challenges and directions in studying cell\u2013cell communication by extracellular vesicles. Nat. Rev. Mol. Cell Biol. 23, 369\u2013382 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"952_CR6","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ccell.2016.09.011","volume":"30","author":"Y Liu","year":"2016","unstructured":"Liu, Y. & Cao, X. Characteristics and significance of the pre-metastatic niche. Cancer Cell 30, 668\u2013681 (2016).","journal-title":"Cancer Cell"},{"key":"952_CR7","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrc.2017.6","volume":"17","author":"H Peinado","year":"2017","unstructured":"Peinado, H. et al. Pre-metastatic niches: organ-specific homes for metastases. Nat. Rev. Cancer 17, 302\u2013317 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"952_CR8","doi-asserted-by":"crossref","unstructured":"Wang, G., Kenific, C. M., Lieberman, G., Zhang, H. & Lyden, D. in The Systemic Effects of Advanced Cancer: A Textbook on Cancer-Associated Cachexia (ed. Swarnali, A.) 9\u201339 (Springer International Publishing, 2022).","DOI":"10.1007\/978-3-031-09518-4_2"},{"key":"952_CR9","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1038\/s41586-025-09898-9","volume":"649","author":"KL Abbott","year":"2026","unstructured":"Abbott, K. L. et al. Nutrient requirements of organ-specific metastasis in breast cancer. Nature 649, 1292\u20131301 (2026).","journal-title":"Nature"},{"key":"952_CR10","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/s41586-022-04758-2","volume":"605","author":"M Rossi","year":"2022","unstructured":"Rossi, M. et al. PHGDH heterogeneity potentiates cancer cell dissemination and metastasis. Nature 605, 747\u2013753 (2022).","journal-title":"Nature"},{"key":"952_CR11","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","volume":"527","author":"A Hoshino","year":"2015","unstructured":"Hoshino, A. et al. Tumour exosome integrins determine organotropic metastasis. Nature 527, 329\u2013335 (2015). This landmark study demonstrates that integrin \u2018zip codes\u2019 direct tumour-secreted EVPs to specific organ sites for specific cellular uptake, answering, in part, the longstanding mystery of Stephen Paget\u2019s \u2018seed and soil\u2019 hypothesis for organotropic metastasis.","journal-title":"Nature"},{"key":"952_CR12","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1158\/1078-0432.CCR-14-2022","volume":"21","author":"N Javeed","year":"2015","unstructured":"Javeed, N. et al. Pancreatic cancer-derived exosomes cause paraneoplastic beta-cell dysfunction. Clin. Cancer Res. 21, 1722\u20131733 (2015).","journal-title":"Clin. Cancer Res."},{"key":"952_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1089","volume":"12","author":"C Shibata","year":"2022","unstructured":"Shibata, C. et al. Lipolysis by pancreatic cancer-derived extracellular vesicles in cancer-associated cachexia via specific integrins. Clin. Transl. Med. 12, e1089 (2022).","journal-title":"Clin. Transl. Med."},{"key":"952_CR14","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41586-023-06114-4","volume":"618","author":"G Wang","year":"2023","unstructured":"Wang, G. et al. Tumour extracellular vesicles and particles induce liver metabolic dysfunction. Nature 618, 374\u2013382 (2023). This key study uncovers that tumour-secreted EVPs promote fatty liver generation in the absence of liver metastasis, leading to metabolic dysregulation that impairs drug metabolism and increases the risk of cardiovascular disease.","journal-title":"Nature"},{"key":"952_CR15","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.ccell.2023.02.018","volume":"41","author":"L Patras","year":"2023","unstructured":"Patras, L., Shaashua, L., Matei, I. & Lyden, D. Immune determinants of the pre-metastatic niche. Cancer Cell 41, 546\u2013572 (2023).","journal-title":"Cancer Cell"},{"key":"952_CR16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","volume":"21","author":"KJ Hiam-Galvez","year":"2021","unstructured":"Hiam-Galvez, K. J., Allen, B. M. & Spitzer, M. H. Systemic immunity in cancer. Nat. Rev. Cancer 21, 345\u2013359 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"952_CR17","doi-asserted-by":"publisher","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","volume":"106","author":"AJ Templeton","year":"2014","unstructured":"Templeton, A. J. et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J. Natl Cancer Inst. 106, dju124 (2014).","journal-title":"J. Natl Cancer Inst."},{"key":"952_CR18","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.1073\/pnas.1320753111","volume":"111","author":"WC Wu","year":"2014","unstructured":"Wu, W. C. et al. Circulating hematopoietic stem and progenitor cells are myeloid-biased in cancer patients. Proc. Natl Acad. Sci. USA 111, 4221\u20134226 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"952_CR19","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1158\/0008-5472.CAN-16-2490","volume":"77","author":"FS Varn","year":"2017","unstructured":"Varn, F. S., Wang, Y., Mullins, D. W., Fiering, S. & Cheng, C. Systematic pan-cancer analysis reveals immune cell interactions in the tumor microenvironment. Cancer Res. 77, 1271\u20131282 (2017).","journal-title":"Cancer Res."},{"key":"952_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50478-8","volume":"15","author":"W Li","year":"2024","unstructured":"Li, W. et al. A single-cell pan-cancer analysis to show the variability of tumor-infiltrating myeloid cells in immune checkpoint blockade. Nat. Commun. 15, 6142 (2024).","journal-title":"Nat. Commun."},{"key":"952_CR21","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.cell.2023.03.007","volume":"186","author":"D Hirschhorn","year":"2023","unstructured":"Hirschhorn, D. et al. T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants. Cell 186, 1432\u20131447.e17 (2023).","journal-title":"Cell"},{"key":"952_CR22","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/s12026-024-09483-8","volume":"72","author":"W Liu","year":"2024","unstructured":"Liu, W. et al. The immunosuppressive landscape in tumor microenvironment. Immunol. Res. 72, 566\u2013582 (2024).","journal-title":"Immunol. Res."},{"key":"952_CR23","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1038\/s41591-024-03075-7","volume":"30","author":"L Bojmar","year":"2024","unstructured":"Bojmar, L. et al. Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer. Nat. Med. 30, 2170\u20132180 (2024).","journal-title":"Nat. Med."},{"key":"952_CR24","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser, K. E. & Joyce, J. A. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell 41, 374\u2013403 (2023).","journal-title":"Cancer Cell"},{"key":"952_CR25","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/s41577-019-0271-z","volume":"20","author":"H Garner","year":"2020","unstructured":"Garner, H. & de Visser, K. E. Immune crosstalk in cancer progression and metastatic spread: a complex conversation. Nat. Rev. Immunol. 20, 483\u2013497 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"952_CR26","doi-asserted-by":"publisher","first-page":"923","DOI":"10.4049\/jimmunol.2400335","volume":"213","author":"TL Whiteside","year":"2024","unstructured":"Whiteside, T. L. Tumor-derived exosomes and antitumor immunity. J. Immunol. 213, 923\u2013931 (2024).","journal-title":"J. Immunol."},{"key":"952_CR27","doi-asserted-by":"publisher","first-page":"6816","DOI":"10.1158\/0008-5472.CAN-16-0868","volume":"76","author":"SW Wen","year":"2016","unstructured":"Wen, S. W. et al. The biodistribution and immune suppressive effects of breast cancer-derived exosomes. Cancer Res. 76, 6816\u20136827 (2016).","journal-title":"Cancer Res."},{"key":"952_CR28","doi-asserted-by":"publisher","first-page":"113751","DOI":"10.1016\/j.celrep.2024.113751","volume":"43","author":"C Deng","year":"2024","unstructured":"Deng, C. et al. Extracellular-vesicle-packaged S100A11 from osteosarcoma cells mediates lung premetastatic niche formation by recruiting gMDSCs. Cell Rep. 43, 113751 (2024).","journal-title":"Cell Rep."},{"key":"952_CR29","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ncb3169","volume":"17","author":"B Costa-Silva","year":"2015","unstructured":"Costa-Silva, B. et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat. Cell Biol. 17, 816\u2013826 (2015).","journal-title":"Nat. Cell Biol."},{"key":"952_CR30","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/j.cmet.2021.09.002","volume":"33","author":"SM Morrissey","year":"2021","unstructured":"Morrissey, S. M. et al. Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming. Cell Metab. 33, 2040\u20132058.e10 (2021).","journal-title":"Cell Metab."},{"key":"952_CR31","doi-asserted-by":"publisher","first-page":"eaah5509","DOI":"10.1126\/sciimmunol.aah5509","volume":"2","author":"F Haderk","year":"2017","unstructured":"Haderk, F. et al. Tumor-derived exosomes modulate PD-L1 expression in monocytes. Sci. Immunol. 2, eaah5509 (2017).","journal-title":"Sci. Immunol."},{"key":"952_CR32","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s00018-017-2724-5","volume":"75","author":"Y Chiba","year":"2018","unstructured":"Chiba, Y. et al. Regulation of myelopoiesis by proinflammatory cytokines in infectious diseases. Cell Mol. Life Sci. 75, 1363\u20131376 (2018).","journal-title":"Cell Mol. Life Sci."},{"key":"952_CR33","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.it.2017.01.004","volume":"38","author":"S Boettcher","year":"2017","unstructured":"Boettcher, S. & Manz, M. G. Regulation of inflammation- and infection-driven hematopoiesis. Trends Immunol. 38, 345\u2013357 (2017).","journal-title":"Trends Immunol."},{"key":"952_CR34","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1182\/blood-2013-12-546416","volume":"124","author":"R Jitschin","year":"2014","unstructured":"Jitschin, R. et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood 124, 750\u2013760 (2014).","journal-title":"Blood"},{"key":"952_CR35","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1165\/rcmb.2016-0361OC","volume":"57","author":"SL Gibbings","year":"2017","unstructured":"Gibbings, S. L. et al. Three unique interstitial macrophages in the murine lung at steady state. Am. J. Respir. Cell Mol. Biol. 57, 66\u201376 (2017).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"952_CR36","doi-asserted-by":"publisher","first-page":"eaau0964","DOI":"10.1126\/science.aau0964","volume":"363","author":"S Chakarov","year":"2019","unstructured":"Chakarov, S. et al. Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches. Science 363, eaau0964 (2019).","journal-title":"Science"},{"key":"952_CR37","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/j.cell.2025.01.025","volume":"188","author":"S Lucotti","year":"2025","unstructured":"Lucotti, S. et al. Extracellular vesicles from the lung pro-thrombotic niche drive cancer-associated thrombosis and metastasis via integrin beta 2. Cell 188, 1642\u20131661.e24 (2025). This landmark work demonstrates that interstitial macrophages residing in the lung PTN secrete EVPs carrying active integrin \u03b22 that binds platelets and promotes systemic clot formation.","journal-title":"Cell"},{"key":"952_CR38","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nm.2753","volume":"18","author":"H Peinado","year":"2012","unstructured":"Peinado, H. et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 18, 883\u2013891 (2012). This groundbreaking study introduces the concept that tumour-derived EVPs communicate with distant organ sites, including targeting and recruitment of bone marrow cells, promoting an immunosuppressive PMN in the lung.","journal-title":"Nat. Med."},{"key":"952_CR39","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.stem.2023.04.005","volume":"30","author":"X Hao","year":"2023","unstructured":"Hao, X. et al. Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal. Cell Stem Cell 30, 648\u2013664.e8 (2023).","journal-title":"Cell Stem Cell"},{"key":"952_CR40","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ccr.2005.08.002","volume":"8","author":"M De Palma","year":"2005","unstructured":"De Palma, M. et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8, 211\u2013226 (2005).","journal-title":"Cancer Cell"},{"key":"952_CR41","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ccell.2014.11.017","volume":"27","author":"H Wang","year":"2015","unstructured":"Wang, H. et al. The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells. Cancer Cell 27, 193\u2013210 (2015).","journal-title":"Cancer Cell"},{"key":"952_CR42","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.ccell.2018.10.002","volume":"34","author":"H Wang","year":"2018","unstructured":"Wang, H. et al. The osteogenic niche is a calcium reservoir of bone micrometastases and confers unexpected therapeutic vulnerability. Cancer Cell 34, 823\u2013839.e7 (2018).","journal-title":"Cancer Cell"},{"key":"952_CR43","doi-asserted-by":"publisher","first-page":"eaar2766","DOI":"10.1126\/sciadv.aar2766","volume":"4","author":"FL Ricklefs","year":"2018","unstructured":"Ricklefs, F. L. et al. Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles. Sci. Adv. 4, eaar2766 (2018).","journal-title":"Sci. Adv."},{"key":"952_CR44","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1158\/2326-6066.CIR-17-0113","volume":"6","author":"GN Shenoy","year":"2018","unstructured":"Shenoy, G. N. et al. Exosomes associated with human ovarian tumors harbor a reversible checkpoint of T-cell responses. Cancer Immunol. Res. 6, 236\u2013247 (2018).","journal-title":"Cancer Immunol. Res."},{"key":"952_CR45","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.3390\/ijms20184411","volume":"20","author":"A Kruger-Genge","year":"2019","unstructured":"Kruger-Genge, A., Blocki, A., Franke, R. P. & Jung, F. Vascular endothelial cell biology: an update. Int. J. Mol. Sci. 20, 4411\u00a0(2019).","journal-title":"Int. J. Mol. Sci."},{"key":"952_CR46","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.3390\/cells11121935","volume":"11","author":"KEM Hellenthal","year":"2022","unstructured":"Hellenthal, K. E. M., Brabenec, L. & Wagner, N. M. Regulation and dysregulation of endothelial permeability during systemic inflammation. Cells 11, 1935\u00a0(2022).","journal-title":"Cells"},{"key":"952_CR47","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.molmed.2020.11.006","volume":"27","author":"L Claesson-Welsh","year":"2021","unstructured":"Claesson-Welsh, L., Dejana, E. & McDonald, D. M. Permeability of the endothelial barrier: identifying and reconciling controversies. Trends Mol. Med. 27, 314\u2013331 (2021).","journal-title":"Trends Mol. Med."},{"key":"952_CR48","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu, D. et al. The blood-brain barrier: structure, regulation, and drug delivery. Signal Transduct. Target. Ther. 8, 217 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"952_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7716","volume":"6","author":"N Tominaga","year":"2015","unstructured":"Tominaga, N. et al. Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier. Nat. Commun. 6, 6716 (2015).","journal-title":"Nat. Commun."},{"key":"952_CR50","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ccr.2014.03.007","volume":"25","author":"W Zhou","year":"2014","unstructured":"Zhou, W. et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell 25, 501\u2013515 (2014).","journal-title":"Cancer Cell"},{"key":"952_CR51","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.3389\/fimmu.2019.01984","volume":"10","author":"SAC McDowell","year":"2019","unstructured":"McDowell, S. A. C. & Quail, D. F. Immunological regulation of vascular inflammation during cancer metastasis. Front. Immunol. 10, 1984 (2019).","journal-title":"Front. Immunol."},{"key":"952_CR52","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13046-024-02991-3","volume":"43","author":"K Li","year":"2024","unstructured":"Li, K. et al. Tumor-derived exosomal ADAM17 promotes pre-metastatic niche formation by enhancing vascular permeability in colorectal cancer. J. Exp. Clin. Cancer Res. 43, 59 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"952_CR53","doi-asserted-by":"publisher","first-page":"13853","DOI":"10.1021\/acsnano.9b04397","volume":"13","author":"G Morad","year":"2019","unstructured":"Morad, G. et al. Tumor-derived extracellular vesicles breach the intact blood-brain barrier via transcytosis. ACS Nano 13, 13853\u201313865 (2019).","journal-title":"ACS Nano"},{"key":"952_CR54","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s41232-022-00225-7","volume":"42","author":"M Kobayashi","year":"2022","unstructured":"Kobayashi, M. et al. Transforming growth factor-\u03b2-induced secretion of extracellular vesicles from oral cancer cells evokes endothelial barrier instability via endothelial-mesenchymal transition. Inflamm. Regen. 42, 38 (2022).","journal-title":"Inflamm. Regen."},{"key":"952_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04037-4","volume":"12","author":"Z Ma","year":"2021","unstructured":"Ma, Z. et al. Tumor-derived exosomal miR-3157-3p promotes angiogenesis, vascular permeability and metastasis by targeting TIMP\/KLF2 in non-small cell lung cancer. Cell Death Dis. 12, 840 (2021).","journal-title":"Cell Death Dis."},{"key":"952_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07810-w","volume":"9","author":"Z Zeng","year":"2018","unstructured":"Zeng, Z. et al. Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis. Nat. Commun. 9, 5395 (2018).","journal-title":"Nat. Commun."},{"key":"952_CR57","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1073\/pnas.61.1.46","volume":"61","author":"GJ Gasic","year":"1968","unstructured":"Gasic, G. J., Gasic, T. B. & Stewart, C. C. Antimetastatic effects associated with platelet reduction. Proc. Natl Acad. Sci. USA 61, 46\u201352 (1968).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"952_CR58","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/ijc.2910110322","volume":"11","author":"GJ Gasic","year":"1973","unstructured":"Gasic, G. J., Gasic, T. B., Galanti, N., Johnson, T. & Murphy, S. Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease. Int. J. Cancer 11, 704\u2013718 (1973).","journal-title":"Int. J. Cancer"},{"key":"952_CR59","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12185-024-03735-x","volume":"119","author":"K Tatsumi","year":"2024","unstructured":"Tatsumi, K. The pathogenesis of cancer-associated thrombosis. Int. J. Hematol. 119, 495\u2013504 (2024).","journal-title":"Int. J. Hematol."},{"key":"952_CR60","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jtha.2023.02.029","volume":"21","author":"A Falanga","year":"2023","unstructured":"Falanga, A. & Marchetti, M. Cancer-associated thrombosis: enhanced awareness and pathophysiologic complexity. J. Thromb. Haemost. 21, 1397\u20131408 (2023).","journal-title":"J. Thromb. Haemost."},{"key":"952_CR61","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1161\/ATVBAHA.120.314378","volume":"41","author":"SP Grover","year":"2021","unstructured":"Grover, S. P., Hisada, Y. M., Kasthuri, R. S., Reeves, B. N. & Mackman, N. Cancer therapy-associated thrombosis. Arterioscler. Thromb. Vasc. Biol. 41, 1291\u20131305 (2021).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"952_CR62","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1634\/theoncologist.2016-0214","volume":"22","author":"E Donnellan","year":"2017","unstructured":"Donnellan, E. & Khorana, A. A. Cancer and venous thromboembolic disease: a review. Oncologist 22, 199\u2013207 (2017).","journal-title":"Oncologist"},{"key":"952_CR63","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.60315","volume":"8","author":"M Zuin","year":"2025","unstructured":"Zuin, M. et al. Pulmonary embolism-related mortality in patients with cancer. JAMA Netw. Open 8, e2460315 (2025).","journal-title":"JAMA Netw. Open"},{"key":"952_CR64","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1126\/science.7195067","volume":"212","author":"HF Dvorak","year":"1981","unstructured":"Dvorak, H. F. et al. Tumor shedding and coagulation. Science 212, 923\u2013924 (1981). This pioneering study demonstrates that tumour-shed EVPs carry potent procoagulant activity capable of activating the clotting cascade, providing an early mechanistic link between EVPs and the prothrombotic state associated with malignancy.","journal-title":"Science"},{"key":"952_CR65","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1111\/j.1538-7836.2008.02987.x","volume":"6","author":"M Davila","year":"2008","unstructured":"Davila, M. et al. Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation. J. Thromb. Haemost. 6, 1517\u20131524 (2008).","journal-title":"J. Thromb. Haemost."},{"key":"952_CR66","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/jth.13181","volume":"14","author":"JE Geddings","year":"2016","unstructured":"Geddings, J. E. et al. Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice. J. Thromb. Haemost. 14, 153\u2013166 (2016).","journal-title":"J. Thromb. Haemost."},{"key":"952_CR67","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1084\/jem.20082297","volume":"206","author":"GM Thomas","year":"2009","unstructured":"Thomas, G. M. et al. Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo. J. Exp. Med. 206, 1913\u20131927 (2009).","journal-title":"J. Exp. Med."},{"key":"952_CR68","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1160\/TH08-10-0654","volume":"101","author":"K Haubold","year":"2009","unstructured":"Haubold, K. et al. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer. Thromb. Haemost. 101, 1147\u20131155 (2009).","journal-title":"Thromb. Haemost."},{"key":"952_CR69","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1160\/TH06-03-0141","volume":"97","author":"G Hron","year":"2007","unstructured":"Hron, G. et al. Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. Thromb. Haemost. 97, 119\u2013123 (2007).","journal-title":"Thromb. Haemost."},{"key":"952_CR70","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.thromres.2009.09.019","volume":"125","author":"DA Manly","year":"2010","unstructured":"Manly, D. A. et al. Increased microparticle tissue factor activity in cancer patients with venous thromboembolism. Thromb. Res. 125, 511\u2013512 (2010).","journal-title":"Thromb. Res."},{"key":"952_CR71","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/j.1538-7836.2007.02369.x","volume":"5","author":"ME Tesselaar","year":"2007","unstructured":"Tesselaar, M. E. et al. Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J. Thromb. Haemost. 5, 520\u2013527 (2007).","journal-title":"J. Thromb. Haemost."},{"key":"952_CR72","doi-asserted-by":"publisher","first-page":"6830","DOI":"10.1158\/1078-0432.CCR-09-0371","volume":"15","author":"JI Zwicker","year":"2009","unstructured":"Zwicker, J. I. et al. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin. Cancer Res. 15, 6830\u20136840 (2009).","journal-title":"Clin. Cancer Res."},{"key":"952_CR73","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.thromres.2017.09.019","volume":"159","author":"FG Gomes","year":"2017","unstructured":"Gomes, F. G. et al. Breast-cancer extracellular vesicles induce platelet activation and aggregation by tissue factor-independent and -dependent mechanisms. Thromb. Res. 159, 24\u201332 (2017).","journal-title":"Thromb. Res."},{"key":"952_CR74","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1182\/blood-2015-01-622811","volume":"126","author":"KF Nickel","year":"2015","unstructured":"Nickel, K. F. et al. The polyphosphate-factor XII pathway drives coagulation in prostate cancer-associated thrombosis. Blood 126, 1379\u20131389 (2015).","journal-title":"Blood"},{"key":"952_CR75","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1182\/bloodadvances.2021005116","volume":"5","author":"YJ Shim","year":"2021","unstructured":"Shim, Y. J. et al. Polyphosphate expression by cancer cell extracellular vesicles mediates binding of factor XII and contact activation. Blood Adv. 5, 4741\u20134751 (2021).","journal-title":"Blood Adv."},{"key":"952_CR76","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1161\/CIRCRESAHA.122.321861","volume":"132","author":"T Dudiki","year":"2023","unstructured":"Dudiki, T. et al. Mechanism of tumor-platelet communications in cancer. Circ. Res. 132, 1447\u20131461 (2023).","journal-title":"Circ. Res."},{"key":"952_CR77","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1182\/bloodadvances.2020002998","volume":"5","author":"N Tawil","year":"2021","unstructured":"Tawil, N. et al. Glioblastoma cell populations with distinct oncogenic programs release podoplanin as procoagulant extracellular vesicles. Blood Adv. 5, 1682\u20131694 (2021).","journal-title":"Blood Adv."},{"key":"952_CR78","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1161\/ATVBAHA.118.312130","volume":"39","author":"SP Grover","year":"2019","unstructured":"Grover, S. P. & Mackman, N. Intrinsic pathway of coagulation and thrombosis. Arterioscler. Thromb. Vasc. Biol. 39, 331\u2013338 (2019).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"952_CR79","doi-asserted-by":"publisher","first-page":"100124","DOI":"10.1016\/j.rpth.2023.100124","volume":"7","author":"ATA Sachetto","year":"2023","unstructured":"Sachetto, A. T. A. et al. Tissue factor activity of small and large extracellular vesicles in different diseases. Res. Pract. Thromb. Haemost. 7, 100124 (2023).","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"952_CR80","doi-asserted-by":"publisher","first-page":"9534","DOI":"10.1038\/s41598-026-42867-4","volume":"16","author":"A Wolff","year":"2026","unstructured":"Wolff, A. et al. Exploring the dual role of extracellular vesicles in coagulation and immune modulation in glioblastoma. Sci. Rep. 16, 9534\u00a0(2026).","journal-title":"Sci. Rep."},{"key":"952_CR81","doi-asserted-by":"publisher","first-page":"25993","DOI":"10.1074\/jbc.M702327200","volume":"282","author":"K Suzuki-Inoue","year":"2007","unstructured":"Suzuki-Inoue, K. et al. Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells. J. Biol. Chem. 282, 25993\u201326001 (2007).","journal-title":"J. Biol. Chem."},{"key":"952_CR82","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1182\/blood-2016-02-701094","volume":"128","author":"EJ Libourel","year":"2016","unstructured":"Libourel, E. J. et al. Disseminated intravascular coagulation at diagnosis is a strong predictor for thrombosis in acute myeloid leukemia. Blood 128, 1854\u20131861 (2016).","journal-title":"Blood"},{"key":"952_CR83","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1055\/s-0037-1616139","volume":"86","author":"S Sallah","year":"2001","unstructured":"Sallah, S., Wan, J. Y., Nguyen, N. P., Hanrahan, L. R. & Sigounas, G. Disseminated intravascular coagulation in solid tumors: clinical and pathologic study. Thromb. Haemost. 86, 828\u2013833 (2001).","journal-title":"Thromb. Haemost."},{"key":"952_CR84","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1055\/s-0039-1687891","volume":"45","author":"N Tawil","year":"2019","unstructured":"Tawil, N., Bassawon, R. & Rak, J. Oncogenes and clotting factors: the emerging role of tumor cell genome and epigenome in cancer-associated thrombosis. Semin. Thromb. Hemost. 45, 373\u2013384 (2019).","journal-title":"Semin. Thromb. Hemost."},{"key":"952_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81268-7","volume":"11","author":"Y Shi","year":"2021","unstructured":"Shi, Y. et al. Neutrophils can promote clotting via FXI and impact clot structure via neutrophil extracellular traps in a distinctive manner in vitro. Sci. Rep. 11, 1718 (2021).","journal-title":"Sci. Rep."},{"key":"952_CR86","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3389\/fimmu.2012.00385","volume":"3","author":"K Kambas","year":"2012","unstructured":"Kambas, K., Mitroulis, I. & Ritis, K. The emerging role of neutrophils in thrombosis-the journey of TF through NETs. Front. Immunol. 3, 385 (2012).","journal-title":"Front. Immunol."},{"key":"952_CR87","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1111\/jth.14222","volume":"16","author":"S Chennakrishnaiah","year":"2018","unstructured":"Chennakrishnaiah, S. et al. Leukocytes as a reservoir of circulating oncogenic DNA and regulatory targets of tumor-derived extracellular vesicles. J. Thromb. Haemost. 16, 1800\u20131813 (2018).","journal-title":"J. Thromb. Haemost."},{"key":"952_CR88","doi-asserted-by":"publisher","first-page":"910908","DOI":"10.3389\/fcimb.2022.910908","volume":"12","author":"Y Zhou","year":"2022","unstructured":"Zhou, Y., Xu, Z. & Liu, Z. Impact of neutrophil extracellular traps on thrombosis formation: new findings and future perspective. Front. Cell Infect. Microbiol. 12, 910908 (2022).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"952_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06893-7","volume":"7","author":"AC Leal","year":"2017","unstructured":"Leal, A. C. et al. Tumor-derived exosomes induce the formation of neutrophil extracellular traps: implications for the establishment of cancer-associated thrombosis. Sci. Rep. 7, 6438 (2017).","journal-title":"Sci. Rep."},{"key":"952_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/srep35376","volume":"6","author":"K Aubertin","year":"2016","unstructured":"Aubertin, K. et al. Massive release of extracellular vesicles from cancer cells after photodynamic treatment or chemotherapy. Sci. Rep. 6, 35376 (2016).","journal-title":"Sci. Rep."},{"key":"952_CR91","doi-asserted-by":"publisher","first-page":"7864","DOI":"10.1158\/0008-5472.CAN-07-6538","volume":"68","author":"BD Lehmann","year":"2008","unstructured":"Lehmann, B. D. et al. Senescence-associated exosome release from human prostate cancer cells. Cancer Res. 68, 7864\u20137871 (2008).","journal-title":"Cancer Res."},{"key":"952_CR92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173685","volume":"12","author":"M Le","year":"2017","unstructured":"Le, M. et al. Exosomes are released by bystander cells exposed to radiation-induced biophoton signals: reconciling the mechanisms mediating the bystander effect. PLoS ONE 12, e0173685 (2017).","journal-title":"PLoS ONE"},{"key":"952_CR93","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41556-018-0256-3","volume":"21","author":"I Keklikoglou","year":"2019","unstructured":"Keklikoglou, I. et al. Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models. Nat. Cell Biol. 21, 190\u2013202 (2019).","journal-title":"Nat. Cell Biol."},{"key":"952_CR94","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.canlet.2020.08.022","volume":"493","author":"SK Bandari","year":"2020","unstructured":"Bandari, S. K., Tripathi, K., Rangarajan, S. & Sanderson, R. D. Therapy-induced chemoexosomes: sinister small extracellular vesicles that support tumor survival and progression. Cancer Lett. 493, 113\u2013119 (2020).","journal-title":"Cancer Lett."},{"key":"952_CR95","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1111\/j.1538-7836.2012.04754.x","volume":"10","author":"J Thaler","year":"2012","unstructured":"Thaler, J. et al. Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients. J. Thromb. Haemost. 10, 1363\u20131370 (2012).","journal-title":"J. Thromb. Haemost."},{"key":"952_CR96","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ygyno.2017.04.021","volume":"146","author":"JG Cohen","year":"2017","unstructured":"Cohen, J. G. et al. Evaluation of venous thrombosis and tissue factor in epithelial ovarian cancer. Gynecol. Oncol. 146, 146\u2013152 (2017).","journal-title":"Gynecol. Oncol."},{"key":"952_CR97","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.3389\/fonc.2020.01350","volume":"10","author":"S Lucotti","year":"2020","unstructured":"Lucotti, S. & Muschel, R. J. Platelets and metastasis: new implications of an old interplay. Front. Oncol. 10, 1350 (2020).","journal-title":"Front. Oncol."},{"key":"952_CR98","doi-asserted-by":"publisher","first-page":"E3053","DOI":"10.1073\/pnas.1411082111","volume":"111","author":"M Labelle","year":"2014","unstructured":"Labelle, M., Begum, S. & Hynes, R. O. Platelets guide the formation of early metastatic niches. Proc. Natl Acad. Sci. USA 111, E3053\u2013E3061 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"952_CR99","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/S0140-6736(12)60209-8","volume":"379","author":"PM Rothwell","year":"2012","unstructured":"Rothwell, P. M. et al. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet 379, 1591\u20131601 (2012).","journal-title":"Lancet"},{"key":"952_CR100","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41568-023-00639-6","volume":"24","author":"S Li","year":"2024","unstructured":"Li, S. et al. The dynamic role of platelets in cancer progression and their therapeutic implications. Nat. Rev. Cancer 24, 72\u201387 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"952_CR101","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1161\/CIRCULATIONAHA.120.048655","volume":"142","author":"J Moslehi","year":"2020","unstructured":"Moslehi, J., Zhang, Q. & Moore, K. J. Crosstalk between the heart and cancer: beyond drug toxicity. Circulation 142, 684\u2013687 (2020).","journal-title":"Circulation"},{"key":"952_CR102","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","volume":"34","author":"NN Pavlova","year":"2022","unstructured":"Pavlova, N. N., Zhu, J. & Thompson, C. B. The hallmarks of cancer metabolism: still emerging. Cell Metab. 34, 355\u2013377 (2022).","journal-title":"Cell Metab."},{"key":"952_CR103","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.devcel.2021.04.013","volume":"56","author":"LA Broadfield","year":"2021","unstructured":"Broadfield, L. A., Pane, A. A., Talebi, A., Swinnen, J. V. & Fendt, S. M. Lipid metabolism in cancer: new perspectives and emerging mechanisms. Dev. Cell 56, 1363\u20131393 (2021).","journal-title":"Dev. Cell"},{"key":"952_CR104","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41556-018-0083-6","volume":"20","author":"W Yan","year":"2018","unstructured":"Yan, W. et al. Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells. Nat. Cell Biol. 20, 597\u2013609 (2018).","journal-title":"Nat. Cell Biol."},{"key":"952_CR105","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1038\/s41388-022-02248-3","volume":"41","author":"Z Zeng","year":"2022","unstructured":"Zeng, Z. et al. HAO1-mediated oxalate metabolism promotes lung pre-metastatic niche formation by inducing neutrophil extracellular traps. Oncogene 41, 3719\u20133731 (2022).","journal-title":"Oncogene"},{"key":"952_CR106","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1158\/1541-7786.MCR-20-0827","volume":"19","author":"A Ikeda","year":"2021","unstructured":"Ikeda, A. et al. Colorectal cancer-derived CAT1-positive extracellular vesicles alter nitric oxide metabolism in endothelial cells and promote angiogenesis. Mol. Cancer Res. 19, 834\u2013846 (2021).","journal-title":"Mol. Cancer Res."},{"key":"952_CR107","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1080\/0284186X.2023.2197124","volume":"62","author":"JM Marmol","year":"2023","unstructured":"Marmol, J. M. et al. Insulin resistance in patients with cancer: a systematic review and meta-analysis. Acta Oncol. 62, 364\u2013371 (2023).","journal-title":"Acta Oncol."},{"key":"952_CR108","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1001\/jamaoncol.2018.1684","volume":"4","author":"Y Hwangbo","year":"2018","unstructured":"Hwangbo, Y. et al. Incidence of diabetes after cancer development: a Korean National Cohort study. JAMA Oncol. 4, 1099\u20131105 (2018).","journal-title":"JAMA Oncol."},{"key":"952_CR109","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1001\/jamaoncol.2019.0695","volume":"5","author":"JC Brown","year":"2019","unstructured":"Brown, J. C. et al. Body composition and cardiovascular events in patients with colorectal cancer: a population-based retrospective cohort study. JAMA Oncol. 5, 967\u2013972 (2019).","journal-title":"JAMA Oncol."},{"key":"952_CR110","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41571-023-00734-5","volume":"20","author":"JM Argiles","year":"2023","unstructured":"Argiles, J. M., Lopez-Soriano, F. J., Stemmler, B. & Busquets, S. Cancer-associated cachexia - understanding the tumour macroenvironment and microenvironment to improve management. Nat. Rev. Clin. Oncol. 20, 250\u2013264 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"952_CR111","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.jhep.2019.08.018","volume":"71","author":"AM Allen","year":"2019","unstructured":"Allen, A. M., Hicks, S. B., Mara, K. C., Larson, J. J. & Therneau, T. M. The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - a longitudinal cohort study. J. Hepatology 71, 1229\u20131236 (2019).","journal-title":"J. Hepatology"},{"key":"952_CR112","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1136\/gutjnl-2021-324191","volume":"71","author":"A Mantovani","year":"2022","unstructured":"Mantovani, A. et al. Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies. Gut 71, 778\u2013788 (2022).","journal-title":"Gut"},{"key":"952_CR113","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S2468-1253(23)00275-3","volume":"9","author":"JA Thomas","year":"2024","unstructured":"Thomas, J. A., Kendall, B. J., El-Serag, H. B., Thrift, A. P. & Macdonald, G. A. Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease. Lancet Gastroenterol. Hepatol. 9, 159\u2013169 (2024).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"952_CR114","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1016\/j.cmet.2025.08.012","volume":"37","author":"C Li","year":"2025","unstructured":"Li, C. et al. Liver-breast communication of adipocyte-oriented exosomes drives primary mammary cancer progression. Cell Metab. 37, 2402-2422.e18\u00a0(2025). This pioneering study provides a direct mechanistic link between fatty liver disease and increased extrahepatic cancer risk by showing that ERBB4- and TRMT10C-carrying fatty liver-derived EVPs act systemically to target and reprogramme distant mammary tissues, thereby promoting breast cancer progression in animal models.","journal-title":"Cell Metab."},{"key":"952_CR115","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1093\/eurheartj\/ehz766","volume":"40","author":"KM Sturgeon","year":"2019","unstructured":"Sturgeon, K. M. et al. A population-based study of cardiovascular disease mortality risk in US cancer patients. Eur. Heart J. 40, 3889\u20133897 (2019).","journal-title":"Eur. Heart J."},{"key":"952_CR116","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15639-5","volume":"11","author":"KC Stoltzfus","year":"2020","unstructured":"Stoltzfus, K. C. et al. Fatal heart disease among cancer patients. Nat. Commun. 11, 2011 (2020).","journal-title":"Nat. Commun."},{"key":"952_CR117","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1200\/JCO.21.01736","volume":"40","author":"H Greenlee","year":"2022","unstructured":"Greenlee, H. et al. Risk of cardiovascular disease in women with and without breast cancer: the Pathways heart study. J. Clin. Oncol. 40, 1647\u20131658 (2022).","journal-title":"J. Clin. Oncol."},{"key":"952_CR118","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41574-021-00542-w","volume":"17","author":"C Mathieu","year":"2021","unstructured":"Mathieu, C., Martens, P. J. & Vangoitsenhoven, R. One hundred years of insulin therapy. Nat. Rev. Endocrinol. 17, 715\u2013725 (2021).","journal-title":"Nat. Rev. Endocrinol."},{"key":"952_CR119","doi-asserted-by":"publisher","first-page":"709","DOI":"10.6004\/jnccn.2020.7653","volume":"19","author":"DJ Ose","year":"2021","unstructured":"Ose, D. J. et al. Understanding the prevalence of prediabetes and diabetes in patients with cancer in clinical practice: a real-world cohort study. J. Natl Compr. Canc Netw. 19, 709\u2013718 (2021).","journal-title":"J. Natl Compr. Canc Netw."},{"issue":"Suppl. 2","key":"952_CR120","doi-asserted-by":"publisher","first-page":"ii18","DOI":"10.1093\/annonc\/mdx815","volume":"29","author":"R Dev","year":"2018","unstructured":"Dev, R., Bruera, E. & Dalal, S. Insulin resistance and body composition in cancer patients. Ann. Oncol. 29 (Suppl. 2), ii18\u2013ii26 (2018).","journal-title":"Ann. Oncol."},{"key":"952_CR121","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","volume":"98","author":"MC Petersen","year":"2018","unstructured":"Petersen, M. C. & Shulman, G. I. Mechanisms of insulin action and insulin resistance. Physiol. Rev. 98, 2133\u20132223 (2018).","journal-title":"Physiol. Rev."},{"key":"952_CR122","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s13539-011-0051-5","volume":"3","author":"MA Honors","year":"2012","unstructured":"Honors, M. A. & Kinzig, K. P. The role of insulin resistance in the development of muscle wasting during cancer cachexia. J. Cachexia Sarcopenia Muscle 3, 5\u201311 (2012).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"952_CR123","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.clnu.2009.11.006","volume":"29","author":"RA Murphy","year":"2010","unstructured":"Murphy, R. A. et al. Loss of adipose tissue and plasma phospholipids: relationship to survival in advanced cancer patients. Clin. Nutr. 29, 482\u2013487 (2010).","journal-title":"Clin. Nutr."},{"key":"952_CR124","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40170-024-00332-8","volume":"12","author":"GT Ruan","year":"2024","unstructured":"Ruan, G. T. et al. Systemic inflammation and insulin resistance-related indicator predicts poor outcome in patients with cancer cachexia. Cancer Metab. 12, 3 (2024).","journal-title":"Cancer Metab."},{"key":"952_CR125","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1053\/j.gastro.2007.08.040","volume":"133","author":"A Flood","year":"2007","unstructured":"Flood, A. et al. Elevated serum concentrations of insulin and glucose increase risk of recurrent colorectal adenomas. Gastroenterology 133, 1423\u20131429 (2007).","journal-title":"Gastroenterology"},{"key":"952_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05541-4","volume":"7","author":"L Wang","year":"2017","unstructured":"Wang, L. et al. Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K\/Akt\/FoxO1 pathway. Sci. Rep. 7, 5384 (2017).","journal-title":"Sci. Rep."},{"key":"952_CR127","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41556-022-00919-7","volume":"24","author":"M Cao","year":"2022","unstructured":"Cao, M. et al. Cancer-cell-secreted extracellular vesicles suppress insulin secretion through miR-122 to impair systemic glucose homeostasis and contribute to tumour growth. Nat. Cell Biol. 24, 954\u2013967 (2022). This important study reveals that tumour-derived EVPs suppress insulin secretion and offset glucose homeostasis, which in turn supports tumour growth.","journal-title":"Nat. Cell Biol."},{"key":"952_CR128","doi-asserted-by":"publisher","first-page":"ar79","DOI":"10.1091\/mbc.E22-12-0560","volume":"34","author":"M Oh","year":"2023","unstructured":"Oh, M., Batty, S., Banerjee, N. & Kim, T. H. High extracellular glucose promotes cell motility by modulating cell deformability and contractility via the cAMP-RhoA-ROCK axis in human breast cancer cells. Mol. Biol. Cell 34, ar79 (2023).","journal-title":"Mol. Biol. Cell"},{"key":"952_CR129","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1152\/physrev.00045.2011","volume":"93","author":"JM Forbes","year":"2013","unstructured":"Forbes, J. M. & Cooper, M. E. Mechanisms of diabetic complications. Physiol. Rev. 93, 137\u2013188 (2013).","journal-title":"Physiol. Rev."},{"key":"952_CR130","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3892\/or.2023.8557","volume":"49","author":"W Qin","year":"2023","unstructured":"Qin, W., Kang, M., Li, C., Zheng, W. & Guo, Q. VNN1 overexpression in pancreatic cancer cells inhibits paraneoplastic islet function by increasing oxidative stress and inducing beta-cell dedifferentiation. Oncol. Rep. 49, 120\u00a0(2023).","journal-title":"Oncol. Rep."},{"key":"952_CR131","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190450","volume":"218","author":"JE Rupert","year":"2021","unstructured":"Rupert, J. E. et al. Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia. J. Exp. Med. 218, e20190450\u00a0(2021).","journal-title":"J. Exp. Med."},{"key":"952_CR132","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2215095120","volume":"120","author":"A Dasgupta","year":"2023","unstructured":"Dasgupta, A. et al. A TGF-beta\/KLF10 signaling axis regulates atrophy-associated genes to induce muscle wasting in pancreatic cancer. Proc. Natl Acad. Sci. USA 120, e2215095120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"952_CR133","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/nm1677","volume":"13","author":"H Johnen","year":"2007","unstructured":"Johnen, H. et al. Tumor-induced anorexia and weight loss are mediated by the TGF-\u03b2\u00a0superfamily cytokine MIC-1. Nat. Med. 13, 1333\u20131340 (2007).","journal-title":"Nat. Med."},{"key":"952_CR134","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41591-018-0054-2","volume":"24","author":"G Wang","year":"2018","unstructured":"Wang, G. et al. Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle. Nat. Med. 24, 770\u2013781 (2018).","journal-title":"Nat. Med."},{"key":"952_CR135","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s42255-024-01011-0","volume":"6","author":"X Liu","year":"2024","unstructured":"Liu, X. et al. Activation of GPR81 by lactate drives tumour-induced cachexia. Nat. Metab. 6, 708\u2013723 (2024).","journal-title":"Nat. Metab."},{"key":"952_CR136","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature13528","volume":"513","author":"S Kir","year":"2014","unstructured":"Kir, S. et al. Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia. Nature 513, 100\u2013104 (2014).","journal-title":"Nature"},{"key":"952_CR137","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41577-021-00624-w","volume":"22","author":"H Baazim","year":"2022","unstructured":"Baazim, H., Antonio-Herrera, L. & Bergthaler, A. The interplay of immunology and cachexia in infection and cancer. Nat. Rev. Immunol. 22, 309\u2013321 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"952_CR138","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13045-023-01454-0","volume":"16","author":"T Setiawan","year":"2023","unstructured":"Setiawan, T. et al. Cancer cachexia: molecular mechanisms and treatment strategies. J. Hematol. Oncol. 16, 54 (2023).","journal-title":"J. Hematol. Oncol."},{"key":"952_CR139","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.1073\/pnas.1402714111","volume":"111","author":"WA He","year":"2014","unstructured":"He, W. A. et al. Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7. Proc. Natl Acad. Sci. USA 111, 4525\u20134529 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"952_CR140","doi-asserted-by":"publisher","first-page":"6680","DOI":"10.1158\/0008-5472.CAN-17-3878","volume":"78","author":"F Calore","year":"2018","unstructured":"Calore, F. et al. The TLR7\/8\/9 antagonist IMO-8503 inhibits cancer-induced cachexia. Cancer Res. 78, 6680\u20136690 (2018).","journal-title":"Cancer Res."},{"key":"952_CR141","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12060","volume":"10","author":"X Gao","year":"2021","unstructured":"Gao, X. et al. Extracellular vesicles derived from oesophageal cancer containing P4HB promote muscle wasting via regulating PHGDH\/Bcl-2\/caspase-3 pathway. J. Extracell. Vesicles 10, e12060 (2021).","journal-title":"J. Extracell. Vesicles"},{"key":"952_CR142","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1053\/j.gastro.2018.10.026","volume":"156","author":"J Yang","year":"2019","unstructured":"Yang, J. et al. ZIP4 promotes muscle wasting and cachexia in mice with orthotopic pancreatic tumors by stimulating RAB27B-regulated release of extracellular vesicles from cancer cells. Gastroenterology 156, 722\u2013734.e6 (2019).","journal-title":"Gastroenterology"},{"key":"952_CR143","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00726-x","volume":"8","author":"G Zhang","year":"2017","unstructured":"Zhang, G. et al. Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90. Nat. Commun. 8, 589 (2017). This key study reveals that tumour-derived HSP70- and HSP90-expressing EVPs contribute to cachexia by activating TLR4-mediated muscle catabolism and driving systemic inflammation.","journal-title":"Nat. Commun."},{"key":"952_CR144","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s41556-022-00893-0","volume":"24","author":"W Yan","year":"2022","unstructured":"Yan, W. et al. Cancer-cell-secreted miR-122 suppresses O-GlcNAcylation to promote skeletal muscle proteolysis. Nat. Cell Biol. 24, 793\u2013804 (2022).","journal-title":"Nat. Cell Biol."},{"key":"952_CR145","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202256464","volume":"24","author":"X Ruan","year":"2023","unstructured":"Ruan, X. et al. Cancer-cell-secreted extracellular vesicles target p53 to impair mitochondrial function in muscle. EMBO Rep. 24, e56464 (2023).","journal-title":"EMBO Rep."},{"key":"952_CR146","doi-asserted-by":"publisher","first-page":"110901","DOI":"10.1016\/j.cellsig.2023.110901","volume":"112","author":"H Xiong","year":"2023","unstructured":"Xiong, H. et al. Exosomal EIF5A derived from Lewis lung carcinoma induced adipocyte wasting in cancer cachexia. Cell Signal. 112, 110901 (2023).","journal-title":"Cell Signal."},{"key":"952_CR147","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03382-0","volume":"12","author":"W Hu","year":"2021","unstructured":"Hu, W. et al. Extracellular vesicles-released parathyroid hormone-related protein from Lewis lung carcinoma induces lipolysis and adipose tissue browning in cancer cachexia. Cell Death Dis. 12, 134 (2021).","journal-title":"Cell Death Dis."},{"key":"952_CR148","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1136\/gutjnl-2014-308350","volume":"65","author":"G Sagar","year":"2016","unstructured":"Sagar, G. et al. Pathogenesis of pancreatic cancer exosome-induced lipolysis in adipose tissue. Gut 65, 1165\u20131174 (2016).","journal-title":"Gut"},{"key":"952_CR149","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40571-9","volume":"14","author":"Y Hu","year":"2023","unstructured":"Hu, Y. et al. Cancer-cell-secreted miR-204-5p induces leptin signalling pathway in white adipose tissue to promote cancer-associated cachexia. Nat. Commun. 14, 5179 (2023). This important study uncovers how tumour-secreted EVP-derived miR-204-5p regulates adipose tissue browning and fat loss via HIF1A.","journal-title":"Nat. Commun."},{"key":"952_CR150","doi-asserted-by":"publisher","first-page":"5338","DOI":"10.7150\/jca.60340","volume":"12","author":"F Wang","year":"2021","unstructured":"Wang, F. et al. Dyslipidemia in Chinese pancreatic cancer patients: a two-center retrospective study. J. Cancer 12, 5338\u20135344 (2021).","journal-title":"J. Cancer"},{"key":"952_CR151","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/cbf.3859","volume":"41","author":"H de Morais","year":"2023","unstructured":"de Morais, H. et al. Peripheral insulin resistance is early, progressive, and correlated with cachexia in Walker-256 tumor-bearing rats. Cell Biochem. Funct. 41, 1252\u20131262 (2023).","journal-title":"Cell Biochem. Funct."},{"key":"952_CR152","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ejphar.2018.11.018","volume":"843","author":"K Renu","year":"2019","unstructured":"Renu, K. et al. Elevated lipolysis in adipose tissue by doxorubicin via PPAR\u03b1\u00a0activation associated with hepatic steatosis and insulin resistance. Eur. J. Pharmacol. 843, 162\u2013176 (2019).","journal-title":"Eur. J. Pharmacol."},{"key":"952_CR153","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fnut.2020.00004","volume":"7","author":"D Riccardi","year":"2020","unstructured":"Riccardi, D. et al. Plasma lipid profile and systemic inflammation in patients with cancer cachexia. Front. Nutr. 7, 4 (2020).","journal-title":"Front. Nutr."},{"key":"952_CR154","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1016\/j.clnu.2021.02.016","volume":"40","author":"A Molfino","year":"2021","unstructured":"Molfino, A. et al. Cancer-associated anorexia: validity and performance overtime of different appetite tools among patients at their first cancer diagnosis. Clin. Nutr. 40, 4037\u20134042 (2021).","journal-title":"Clin. Nutr."},{"key":"952_CR155","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/jcsm.12059","volume":"6","author":"CC Ezeoke","year":"2015","unstructured":"Ezeoke, C. C. & Morley, J. E. Pathophysiology of anorexia in the cancer cachexia syndrome. J. Cachexia Sarcopenia Muscle 6, 287\u2013302 (2015).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"952_CR156","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202504064","volume":"12","author":"K Xu","year":"2025","unstructured":"Xu, K. et al. Pancreatic cancer-derived extracellular vesicles enriched with miR-223-5p promote skeletal muscle wasting associated with cachexia. Adv. Sci. 12, e04064 (2025).","journal-title":"Adv. Sci."},{"key":"952_CR157","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.21873\/anticanres.16426","volume":"43","author":"J Buentzel","year":"2023","unstructured":"Buentzel, J., Schulz, M., Aperdannier, L., Bleckmann, A. & Binder, C. Metabolic changes in blood-derived extracellular vesicles of malnourished breast cancer patients. Anticancer. Res. 43, 2593\u20132599 (2023).","journal-title":"Anticancer. Res."},{"key":"952_CR158","doi-asserted-by":"publisher","first-page":"15896","DOI":"10.1021\/acsnano.5c01564","volume":"19","author":"W Zeng","year":"2025","unstructured":"Zeng, W. et al. Chemical affinity capture of plasma extracellular vesicles enables efficient and large-scale proteomic identification of prostate cancer biomarkers. ACS Nano 19, 15896\u201315911 (2025).","journal-title":"ACS Nano"},{"key":"952_CR159","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/jcsm.12033","volume":"6","author":"L Lerner","year":"2015","unstructured":"Lerner, L. et al. Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients. J. Cachexia Sarcopenia Muscle 6, 317\u2013324 (2015).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"952_CR160","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1056\/NEJMoa2409515","volume":"391","author":"JD Groarke","year":"2024","unstructured":"Groarke, J. D. et al. Ponsegromab for the treatment of cancer cachexia. N. Engl. J. Med. 391, 2291-2303\u00a0(2024).","journal-title":"N. Engl. J. Med."},{"key":"952_CR161","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1002\/jcsm.13079","volume":"13","author":"M Fan","year":"2022","unstructured":"Fan, M. et al. Atractylenolide I ameliorates cancer cachexia through inhibiting biogenesis of IL-6 and tumour-derived extracellular vesicles. J. Cachexia Sarcopenia 13, 2724\u20132739 (2022).","journal-title":"J. Cachexia Sarcopenia"},{"key":"952_CR162","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/s41388-021-02151-3","volume":"41","author":"M Fan","year":"2022","unstructured":"Fan, M. et al. The critical role of STAT3 in biogenesis of tumor-derived exosomes with potency of inducing cancer cachexia in vitro and in vivo. Oncogene 41, 1050\u20131062 (2022).","journal-title":"Oncogene"},{"key":"952_CR163","doi-asserted-by":"publisher","DOI":"10.1186\/s13395-021-00274-5","volume":"11","author":"L Zhou","year":"2021","unstructured":"Zhou, L. et al. Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome release. Skelet. Muscle 11, 17 (2021).","journal-title":"Skelet. Muscle"},{"key":"952_CR164","doi-asserted-by":"publisher","first-page":"838","DOI":"10.4065\/mcp.2010.0099","volume":"85","author":"LC Pelosof","year":"2010","unstructured":"Pelosof, L. C. & Gerber, D. E. Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin. Proc. 85, 838\u2013854 (2010).","journal-title":"Mayo Clin. Proc."},{"key":"952_CR165","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau, J. & Rosenfeld, M. R. Paraneoplastic syndromes of the CNS. Lancet Neurol. 7, 327\u2013340 (2008).","journal-title":"Lancet Neurol."},{"key":"952_CR166","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.cell.2024.01.009","volume":"187","author":"J Xu","year":"2024","unstructured":"Xu, J. et al. PNMA2 forms immunogenic non-enveloped virus-like capsids associated with paraneoplastic neurological syndrome. Cell 187, 831\u2013845.e19 (2024). This landmark work identifies how PNMA2 capsid epitopes act as extracellular antigens that support a paraneoplastic syndrome in the CNS.","journal-title":"Cell"},{"key":"952_CR167","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00401-017-1802-y","volume":"135","author":"M Small","year":"2018","unstructured":"Small, M. et al. Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration. Acta Neuropathol. 135, 569\u2013579 (2018).","journal-title":"Acta Neuropathol."},{"key":"952_CR168","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1002\/acn3.52232","volume":"11","author":"E Tveit Solheim","year":"2024","unstructured":"Tveit Solheim, E. et al. Altered exosomal miRNA profiles in patients with paraneoplastic cerebellar degeneration. Ann. Clin. Transl. Neurol. 11, 3255\u20133266 (2024).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"952_CR169","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1093\/annonc\/mdz410","volume":"30","author":"M Lange","year":"2019","unstructured":"Lange, M. et al. Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors. Ann. Oncol. 30, 1925\u20131940 (2019).","journal-title":"Ann. Oncol."},{"key":"952_CR170","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/S1470-2045(11)70002-X","volume":"12","author":"AJ Mitchell","year":"2011","unstructured":"Mitchell, A. J. et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 12, 160\u2013174 (2011).","journal-title":"Lancet Oncol."},{"key":"952_CR171","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1016\/j.celrep.2020.01.089","volume":"30","author":"X Gao","year":"2020","unstructured":"Gao, X. et al. Gliomas interact with non-glioma brain cells via extracellular vesicles. Cell Rep. 30, 2489\u20132500.e5 (2020).","journal-title":"Cell Rep."},{"key":"952_CR172","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai, E. et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat. Rev. Cancer 20, 174\u2013186 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"952_CR173","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41368-023-00236-1","volume":"15","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. Carcinoma-associated fibroblast-derived lysyl oxidase-rich extracellular vesicles mediate collagen crosslinking and promote epithelial-mesenchymal transition via p-FAK\/p-paxillin\/YAP signaling. Int. J. Oral. Sci. 15, 32 (2023).","journal-title":"Int. J. Oral. Sci."},{"key":"952_CR174","doi-asserted-by":"publisher","first-page":"1578525","DOI":"10.1080\/20013078.2019.1578525","volume":"8","author":"MR Dourado","year":"2019","unstructured":"Dourado, M. R. et al. Extracellular vesicles derived from cancer-associated fibroblasts induce the migration and invasion of oral squamous cell carcinoma. J. Extracell. Vesicles 8, 1578525 (2019).","journal-title":"J. Extracell. Vesicles"},{"key":"952_CR175","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.10250","volume":"5","author":"H Zhao","year":"2016","unstructured":"Zhao, H. et al. Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism. eLife 5, e10250 (2016).","journal-title":"eLife"},{"key":"952_CR176","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.7150\/thno.69590","volume":"12","author":"H Yang","year":"2022","unstructured":"Yang, H. et al. Multi-scale integrative analyses identify THBS2+ cancer-associated fibroblasts as a key orchestrator promoting aggressiveness in early-stage lung adenocarcinoma. Theranostics 12, 3104\u20133130 (2022).","journal-title":"Theranostics"},{"key":"952_CR177","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.cell.2014.09.051","volume":"159","author":"MC Boelens","year":"2014","unstructured":"Boelens, M. C. et al. Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways. Cell 159, 499\u2013513 (2014). This key study illustrates that stromal cell-secreted EVP-derived RNA activates RIGI antiviral signalling and the NOTCH3 pathway in breast cancer cells, initiating processes that enhance the expansion of therapy-resistant tumour-initiating cells.","journal-title":"Cell"},{"key":"952_CR178","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12342","volume":"12","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Stromal cell-derived small extracellular vesicles enhance radioresistance of prostate cancer cells via interleukin-8-induced autophagy. J. Extracell. Vesicles 12, e12342 (2023).","journal-title":"J. Extracell. Vesicles"},{"key":"952_CR179","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3390\/medicina58070889","volume":"58","author":"T Saleh","year":"2022","unstructured":"Saleh, T. et al. Effect of autophagy inhibitors on radiosensitivity in DNA repair-proficient and -deficient glioma cells. Medicina 58, 889\u00a0(2022).","journal-title":"Medicina"},{"key":"952_CR180","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1101\/gad.335570.119","volume":"34","author":"Y Yang","year":"2020","unstructured":"Yang, Y. et al. Autophagy promotes mammalian survival by suppressing oxidative stress and p53. Genes Dev. 34, 688\u2013700 (2020).","journal-title":"Genes Dev."},{"key":"952_CR181","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ccr.2006.06.001","volume":"10","author":"K Degenhardt","year":"2006","unstructured":"Degenhardt, K. et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10, 51\u201364 (2006).","journal-title":"Cancer Cell"},{"key":"952_CR182","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s13046-023-02854-3","volume":"42","author":"S Zheng","year":"2023","unstructured":"Zheng, S. et al. Extracellular vesicle-packaged circBIRC6 from cancer-associated fibroblasts induce platinum resistance via SUMOylation modulation in pancreatic cancer. J. Exp. Clin. Cancer Res. 42, 324 (2023).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"952_CR183","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12228","volume":"11","author":"MS Njock","year":"2022","unstructured":"Njock, M. S. et al. Endothelial extracellular vesicles promote tumour growth by tumour-associated macrophage reprogramming. J. Extracell. Vesicles 11, e12228 (2022).","journal-title":"J. Extracell. Vesicles"},{"key":"952_CR184","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41556-019-0299-0","volume":"21","author":"F Chen","year":"2019","unstructured":"Chen, F. et al. Extracellular vesicle-packaged HIF-1\u03b1-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells. Nat. Cell Biol. 21, 498\u2013510 (2019).","journal-title":"Nat. Cell Biol."},{"key":"952_CR185","doi-asserted-by":"publisher","first-page":"113224","DOI":"10.1016\/j.celrep.2023.113224","volume":"42","author":"W Zhong","year":"2023","unstructured":"Zhong, W. et al. Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunity. Cell Rep. 42, 113224 (2023).","journal-title":"Cell Rep."},{"key":"952_CR186","doi-asserted-by":"publisher","first-page":"1588538","DOI":"10.1080\/20013078.2019.1588538","volume":"8","author":"CH Wu","year":"2019","unstructured":"Wu, C. H. et al. Extracellular vesicles derived from natural killer cells use multiple cytotoxic proteins and killing mechanisms to target cancer cells. J. Extracell. Vesicles 8, 1588538 (2019).","journal-title":"J. Extracell. Vesicles"},{"key":"952_CR187","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02865-1","volume":"9","author":"N Seo","year":"2018","unstructured":"Seo, N. et al. Activated CD8+ T cell extracellular vesicles prevent tumour progression by targeting of lesional mesenchymal cells. Nat. Commun. 9, 435 (2018).","journal-title":"Nat. Commun."},{"key":"952_CR188","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.1038\/s41388-021-01896-1","volume":"40","author":"Y Qiu","year":"2021","unstructured":"Qiu, Y. et al. Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast cancer. Oncogene 40, 4992\u20135001 (2021).","journal-title":"Oncogene"},{"key":"952_CR189","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004942","volume":"4","author":"S Viaud","year":"2009","unstructured":"Viaud, S. et al. Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha. PLoS ONE 4, e4942 (2009).","journal-title":"PLoS ONE"},{"key":"952_CR190","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.ccell.2020.05.002","volume":"37","author":"MK Ruhland","year":"2020","unstructured":"Ruhland, M. K. et al. Visualizing synaptic transfer of tumor antigens among dendritic cells. Cancer Cell 37, 786\u2013799.e5 (2020).","journal-title":"Cancer Cell"},{"key":"952_CR191","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1056\/NEJMsr1606602","volume":"375","author":"B Lauby-Secretan","year":"2016","unstructured":"Lauby-Secretan, B. et al. Body fatness and cancer\u2014viewpoint of the IARC Working Group. N. Engl. J. Med. 375, 794\u2013798 (2016).","journal-title":"N. Engl. J. Med."},{"key":"952_CR192","doi-asserted-by":"publisher","first-page":"20160485","DOI":"10.1098\/rstb.2016.0485","volume":"373","author":"L Robado de Lope","year":"2018","unstructured":"Robado de Lope, L., Alcibar, O. L., Amor Lopez, A., Hergueta-Redondo, M. & Peinado, H. Tumour-adipose tissue crosstalk: fuelling tumour metastasis by extracellular vesicles. Philos. Trans. R. Soc. Lond. B Biol. Sci. 373, 20160485\u00a0(2018).","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"952_CR193","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.3520","volume":"4","author":"F Petrelli","year":"2021","unstructured":"Petrelli, F. et al. Association of obesity with survival outcomes in patients with cancer: a systematic review and meta-analysis. JAMA Netw. Open 4, e213520 (2021).","journal-title":"JAMA Netw. Open"},{"key":"952_CR194","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202357339","volume":"24","author":"S Liu","year":"2023","unstructured":"Liu, S. et al. Breast adipose tissue-derived extracellular vesicles from obese women alter tumor cell metabolism. EMBO Rep. 24, e57339 (2023).","journal-title":"EMBO Rep."},{"key":"952_CR195","doi-asserted-by":"publisher","first-page":"eabj2807","DOI":"10.1126\/scisignal.abj2807","volume":"14","author":"N Jafari","year":"2021","unstructured":"Jafari, N. et al. Adipocyte-derived exosomes may promote breast cancer progression in type 2 diabetes. Sci. Signal. 14, eabj2807 (2021).","journal-title":"Sci. Signal."},{"key":"952_CR196","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.1158\/0008-5472.CAN-16-0651","volume":"76","author":"I Lazar","year":"2016","unstructured":"Lazar, I. et al. Adipocyte exosomes promote melanoma aggressiveness through fatty acid oxidation: a novel mechanism linking obesity and cancer. Cancer Res. 76, 4051\u20134057 (2016).","journal-title":"Cancer Res."},{"key":"952_CR197","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2019102525","volume":"39","author":"E Clement","year":"2020","unstructured":"Clement, E. et al. Adipocyte extracellular vesicles carry enzymes and fatty acids that stimulate mitochondrial metabolism and remodeling in tumor cells. EMBO J. 39, e102525 (2020).","journal-title":"EMBO J."},{"key":"952_CR198","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45995-5","volume":"15","author":"K Xu","year":"2024","unstructured":"Xu, K. et al. Elevated extracellular matrix protein 1 in circulating extracellular vesicles supports breast cancer progression under obesity conditions. Nat. Commun. 15, 1685 (2024).","journal-title":"Nat. Commun."},{"key":"952_CR199","doi-asserted-by":"publisher","first-page":"6055","DOI":"10.1038\/onc.2015.54","volume":"34","author":"KM Lee","year":"2015","unstructured":"Lee, K. M. et al. ECM1 regulates tumor metastasis and CSC-like property through stabilization of \u03b2-catenin. Oncogene 34, 6055\u20136065 (2015).","journal-title":"Oncogene"},{"key":"952_CR200","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41374-020-0415-6","volume":"100","author":"SS Steinhaeuser","year":"2020","unstructured":"Steinhaeuser, S. S. et al. ECM1 secreted by HER2-overexpressing breast cancer cells promotes formation of a vascular niche accelerating cancer cell migration and invasion. Lab. Invest. 100, 928\u2013944 (2020).","journal-title":"Lab. Invest."},{"key":"952_CR201","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.jhep.2021.10.025","volume":"76","author":"JV Lazarus","year":"2022","unstructured":"Lazarus, J. V. et al. The global NAFLD policy review and preparedness index: are countries ready to address this silent public health challenge? J. Hepatol. 76, 771\u2013780 (2022).","journal-title":"J. Hepatol."},{"key":"952_CR202","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.cmet.2023.04.013","volume":"35","author":"Z Wang","year":"2023","unstructured":"Wang, Z. et al. Extracellular vesicles in fatty liver promote a metastatic tumor microenvironment. Cell Metab. 35, 1209\u20131226.e13 (2023).","journal-title":"Cell Metab."},{"key":"952_CR203","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/s41556-019-0404-4","volume":"21","author":"G Rodrigues","year":"2019","unstructured":"Rodrigues, G. et al. Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis. Nat. Cell Biol. 21, 1403\u20131412 (2019).","journal-title":"Nat. Cell Biol."},{"key":"952_CR204","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1158\/0008-5472.CAN-21-1331","volume":"82","author":"XQ Li","year":"2022","unstructured":"Li, X. Q., Zhang, R., Lu, H., Yue, X. M. & Huang, Y. F. Extracellular vesicle-packaged CDH11 and ITGA5 induce the premetastatic niche for bone colonization of breast cancer cells. Cancer Res. 82, 1560\u20131574 (2022).","journal-title":"Cancer Res."},{"key":"952_CR205","doi-asserted-by":"publisher","first-page":"4843","DOI":"10.1158\/1078-0432.CCR-16-2819","volume":"23","author":"S Ludwig","year":"2017","unstructured":"Ludwig, S. et al. Suppression of lymphocyte functions by plasma exosomes correlates with disease activity in patients with head and neck cancer. Clin. Cancer Res. 23, 4843\u20134854 (2017).","journal-title":"Clin. Cancer Res."},{"key":"952_CR206","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","volume":"560","author":"G Chen","year":"2018","unstructured":"Chen, G. et al. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature 560, 382\u2013386 (2018). This landmark study uncovers a novel mechanism by which tumour cells suppress immune function and limit responses to anti-PD1 therapy by releasing PDL1-bearing EVPs that inhibit CD8\u207a T cell activity. Notably, early increases in circulating EVP\u2013PDL1 during treatment stratified responders from non-responders, establishing EVP\u2013PDL1 as both a mediator of immune evasion and a predictive biomarker of therapeutic outcome.","journal-title":"Nature"},{"key":"952_CR207","doi-asserted-by":"publisher","first-page":"217486","DOI":"10.1016\/j.canlet.2025.217486","volume":"612","author":"X Wang","year":"2025","unstructured":"Wang, X. et al. Tumor-derived extracellular vesicle PD-1 promotes tumor immune evasion via disruption of peripheral T cell homeostasis. Cancer Lett. 612, 217486 (2025).","journal-title":"Cancer Lett."},{"key":"952_CR208","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1158\/1078-0432.CCR-17-2664","volume":"24","author":"MN Theodoraki","year":"2018","unstructured":"Theodoraki, M. N., Yerneni, S. S., Hoffmann, T. K., Gooding, W. E. & Whiteside, T. L. Clinical significance of PD-L1+ exosomes in plasma of head and neck cancer patients. Clin. Cancer Res. 24, 896\u2013905 (2018).","journal-title":"Clin. Cancer Res."},{"key":"952_CR209","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1200\/JCO.2015.64.0268","volume":"34","author":"F Macbeth","year":"2016","unstructured":"Macbeth, F. et al. Randomized phase III trial of standard therapy plus low molecular weight heparin in patients with lung cancer: FRAGMATIC trial. J. Clin. Oncol. 34, 488\u2013494 (2016).","journal-title":"J. Clin. Oncol."},{"key":"952_CR210","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1111\/jth.14305","volume":"16","author":"JJ Lopez-Nunez","year":"2018","unstructured":"Lopez-Nunez, J. J., Trujillo-Santos, J. & Monreal, M. Management of venous thromboembolism in patients with cancer. J. Thromb. Haemost. 16, 2391\u20132396 (2018).","journal-title":"J. Thromb. Haemost."},{"key":"952_CR211","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ccell.2018.12.001","volume":"35","author":"A Ortiz","year":"2019","unstructured":"Ortiz, A. et al. An interferon-driven oxysterol-based defense against tumor-derived extracellular vesicles. Cancer Cell 35, 33\u201345.e6 (2019).","journal-title":"Cancer Cell"},{"key":"952_CR212","doi-asserted-by":"publisher","first-page":"101171","DOI":"10.1016\/j.xcrm.2023.101171","volume":"4","author":"S Heidegger","year":"2023","unstructured":"Heidegger, S. et al. Targeting nucleic acid sensors in tumor cells to reprogram biogenesis and RNA cargo of extracellular vesicles for T cell-mediated cancer immunotherapy. Cell Rep. Med. 4, 101171 (2023).","journal-title":"Cell Rep. Med."},{"key":"952_CR213","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202308335","volume":"20","author":"B Wu","year":"2024","unstructured":"Wu, B. et al. Chiral supramolecular nanofibers regulated tumor-derived exosomes secretion for constructing an anti-tumor extracellular microenvironment. Small 20, e2308335 (2024).","journal-title":"Small"},{"key":"952_CR214","doi-asserted-by":"publisher","first-page":"152109","DOI":"10.1016\/j.bbrc.2025.152109","volume":"775","author":"TT Wang","year":"2025","unstructured":"Wang, T. T., Li, Z. Z., Cai, Y., Ren, J. G. & Zhao, J. H. Emerging roles of Rab27 proteins: from normal to cancer stem cells. Biochem. Biophys. Res. Commun. 775, 152109 (2025).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"952_CR215","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/s41563-023-01515-2","volume":"22","author":"S Shin","year":"2023","unstructured":"Shin, S. et al. Curvature-sensing peptide inhibits tumour-derived exosomes for enhanced cancer immunotherapy. Nat. Mater. 22, 656\u2013665 (2023). This work pioneers the concept of targeted disruption of tumour-derived EVPs using an engineered antiviral peptide, enhancing ICB therapy by restoring T cell function, reducing EVP\u2013PDL1, and reshaping the TME to improve cancer outcomes.","journal-title":"Nat. Mater."},{"key":"952_CR216","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jdcr.2021.09.010","volume":"17","author":"A Rea","year":"2021","unstructured":"Rea, A. et al. Eosinophilic fasciitis as a paraneoplastic syndrome in melanoma. JAAD Case Rep. 17, 49\u201351 (2021).","journal-title":"JAAD Case Rep."},{"key":"952_CR217","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s13691-023-00646-2","volume":"13","author":"M Fujino","year":"2024","unstructured":"Fujino, M. et al. Remarkable remission of symptomatic dermatomyositis after curative breast cancer surgery. Int. Cancer Conf. J. 13, 111\u2013118 (2024).","journal-title":"Int. Cancer Conf. J."},{"key":"952_CR218","doi-asserted-by":"publisher","first-page":"1506592","DOI":"10.3389\/fmed.2025.1506592","volume":"12","author":"A Singh Singh","year":"2025","unstructured":"Singh Singh, A. et al. Successful treatment of renal cell carcinoma with paraneoplastic nephrotic syndrome: a case report. Front. Med. 12, 1506592 (2025).","journal-title":"Front. Med."},{"key":"952_CR219","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.70038","volume":"14","author":"S Busatto","year":"2025","unstructured":"Busatto, S. et al. Breast cancer-derived extracellular vesicles modulate the cytoplasmic and cytoskeletal dynamics of blood-brain barrier endothelial cells. J. Extracell. Vesicles 14, e70038 (2025).","journal-title":"J. Extracell. Vesicles"},{"key":"952_CR220","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1038\/s41563-024-02114-5","volume":"24","author":"C Wang","year":"2025","unstructured":"Wang, C. et al. Blood-brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system. Nat. Mater. 24, 1653\u20131663 (2025).","journal-title":"Nat. Mater."},{"key":"952_CR221","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12134","volume":"10","author":"MM Shi","year":"2021","unstructured":"Shi, M. M. et al. Preclinical efficacy and clinical safety of clinical-grade nebulized allogenic adipose mesenchymal stromal cells-derived extracellular vesicles. J. Extracell. Vesicles 10, e12134 (2021).","journal-title":"J. Extracell. Vesicles"},{"key":"952_CR222","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42402-3","volume":"14","author":"CL Chiang","year":"2023","unstructured":"Chiang, C. L. et al. Dual targeted extracellular vesicles regulate oncogenic genes in advanced pancreatic cancer. Nat. Commun. 14, 6692 (2023).","journal-title":"Nat. Commun."},{"key":"952_CR223","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15384047.2022.2123675","volume":"23","author":"C Li","year":"2022","unstructured":"Li, C., Sun, Z., Song, Y. & Zhang, Y. Suppressive function of bone marrow-derived mesenchymal stem cell-derived exosomal microRNA-187 in prostate cancer. Cancer Biol. Ther. 23, 1\u201314 (2022).","journal-title":"Cancer Biol. Ther."},{"key":"952_CR224","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-025-03689-y","volume":"25","author":"FA Attar","year":"2025","unstructured":"Attar, F. A. et al. Doxorubicin loaded exosomes inhibit cancer-associated fibroblasts growth: in vitro and in vivo study. Cancer Cell Int. 25, 72 (2025).","journal-title":"Cancer Cell Int."},{"key":"952_CR225","doi-asserted-by":"publisher","first-page":"eabj8207","DOI":"10.1126\/sciadv.abj8207","volume":"8","author":"J Zhang","year":"2022","unstructured":"Zhang, J. et al. Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy. Sci. Adv. 8, eabj8207 (2022).","journal-title":"Sci. Adv."},{"key":"952_CR226","doi-asserted-by":"publisher","first-page":"113138","DOI":"10.1016\/j.celrep.2023.113138","volume":"42","author":"F Xu","year":"2023","unstructured":"Xu, F. et al. Engineering of dendritic cell bispecific extracellular vesicles for tumor-targeting immunotherapy. Cell Rep. 42, 113138 (2023).","journal-title":"Cell Rep."},{"key":"952_CR227","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12929-020-00633-2","volume":"27","author":"YW Wu","year":"2020","unstructured":"Wu, Y. W. et al. Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop. J. Biomed. Sci. 27, 45 (2020).","journal-title":"J. Biomed. Sci."},{"key":"952_CR228","doi-asserted-by":"publisher","first-page":"121384","DOI":"10.1016\/j.biomaterials.2022.121384","volume":"282","author":"Y Ma","year":"2022","unstructured":"Ma, Y. et al. A cascade synergetic strategy induced by photothermal effect based on platelet exosome nanoparticles for tumor therapy. Biomaterials 282, 121384 (2022).","journal-title":"Biomaterials"},{"key":"952_CR229","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202304187","volume":"35","author":"J Chen","year":"2023","unstructured":"Chen, J. et al. Fruit-derived extracellular-vesicle-engineered structural droplet drugs for enhanced glioblastoma chemotherapy. Adv. Mater. 35, e2304187 (2023).","journal-title":"Adv. Mater."},{"key":"952_CR230","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jconrel.2025.01.029","volume":"379","author":"Z Guo","year":"2025","unstructured":"Guo, Z. et al. Antibody functionalized curcuma-derived extracellular vesicles loaded with doxorubicin overcome therapy-induced senescence and enhance chemotherapy. J. Control. Rel. 379, 377\u2013389 (2025).","journal-title":"J. Control. Rel."},{"key":"952_CR231","doi-asserted-by":"publisher","first-page":"31794","DOI":"10.1021\/acsnano.4c07000","volume":"18","author":"X Pang","year":"2024","unstructured":"Pang, X. et al. Targeted elimination of the oral pathogen to overcome chemoresistance of oral squamous cell carcinoma by biologically derived nanotherapeutics. ACS Nano 18, 31794\u201331808 (2024).","journal-title":"ACS Nano"},{"key":"952_CR232","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00556-3","volume":"8","author":"S Corvigno","year":"2024","unstructured":"Corvigno, S. et al. Enhanced plant-derived vesicles for nucleotide delivery for cancer therapy. NPJ Precis. Oncol. 8, 86 (2024).","journal-title":"NPJ Precis. Oncol."},{"key":"952_CR233","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00729-8","volume":"8","author":"OY Kim","year":"2017","unstructured":"Kim, O. Y. et al. Bacterial outer membrane vesicles suppress tumor by interferon-gamma-mediated antitumor response. Nat. Commun. 8, 626 (2017).","journal-title":"Nat. Commun."},{"key":"952_CR234","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202002085","volume":"32","author":"S Qing","year":"2020","unstructured":"Qing, S. et al. Biomineralized bacterial outer membrane vesicles potentiate safe and efficient tumor microenvironment reprogramming for anticancer therapy. Adv. Mater. 32, e2002085 (2020).","journal-title":"Adv. Mater."},{"key":"952_CR235","doi-asserted-by":"publisher","first-page":"eaba2735","DOI":"10.1126\/sciadv.aba2735","volume":"6","author":"LH Peng","year":"2020","unstructured":"Peng, L. H. et al. Engineering bacterial outer membrane vesicles as transdermal nanoplatforms for photo-TRAIL-programmed therapy against melanoma. Sci. Adv. 6, eaba2735 (2020).","journal-title":"Sci. Adv."},{"key":"952_CR236","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.apsb.2020.02.002","volume":"10","author":"K Kuerban","year":"2020","unstructured":"Kuerban, K. et al. Doxorubicin-loaded bacterial outer-membrane vesicles exert enhanced anti-tumor efficacy in non-small-cell lung cancer. Acta Pharm. Sin. B 10, 1534\u20131548 (2020).","journal-title":"Acta Pharm. Sin. B"},{"key":"952_CR237","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22308-8","volume":"12","author":"K Cheng","year":"2021","unstructured":"Cheng, K. et al. Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via plug-and-display technology. Nat. Commun. 12, 2041 (2021).","journal-title":"Nat. Commun."},{"key":"952_CR238","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1038\/s41551-024-01214-6","volume":"8","author":"OPB Wiklander","year":"2024","unstructured":"Wiklander, O. P. B. et al. Antibody-displaying extracellular vesicles for targeted cancer therapy. Nat. Biomed. Eng. 8, 1453\u20131468\u00a0(2024).","journal-title":"Nat. Biomed. Eng."},{"key":"952_CR239","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43914-8","volume":"14","author":"R Bhatta","year":"2023","unstructured":"Bhatta, R. et al. Metabolic tagging of extracellular vesicles and development of enhanced extracellular vesicle based cancer vaccines. Nat. Commun. 14, 8047 (2023).","journal-title":"Nat. Commun."},{"key":"952_CR240","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.ymthe.2017.03.030","volume":"25","author":"U Sterzenbach","year":"2017","unstructured":"Sterzenbach, U. et al. Engineered exosomes as vehicles for biologically active proteins. Mol. Ther. 25, 1269\u20131278 (2017).","journal-title":"Mol. Ther."},{"key":"952_CR241","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41565-023-01580-3","volume":"19","author":"M Liu","year":"2024","unstructured":"Liu, M., Hu, S., Yan, N., Popowski, K. D. & Cheng, K. Inhalable extracellular vesicle delivery of IL-12 mRNA to treat lung cancer and promote systemic immunity. Nat. Nanotechnol. 19, 565\u2013575 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"952_CR242","doi-asserted-by":"publisher","first-page":"575597","DOI":"10.3389\/fimmu.2020.575597","volume":"11","author":"KG Nguyen","year":"2020","unstructured":"Nguyen, K. G. et al. Localized interleukin-12 for cancer immunotherapy. Front. Immunol. 11, 575597 (2020).","journal-title":"Front. Immunol."},{"key":"952_CR243","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1016\/j.cell.2021.02.048","volume":"184","author":"S Kaczanowska","year":"2021","unstructured":"Kaczanowska, S. et al. Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis. Cell 184, 2033\u20132052.e21 (2021).","journal-title":"Cell"},{"key":"952_CR244","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41392-023-01704-0","volume":"9","author":"F Tan","year":"2024","unstructured":"Tan, F. et al. Clinical applications of stem cell-derived exosomes. Signal Transduct. Target. Ther. 9, 17 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"952_CR245","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT05375604 (2023)."},{"key":"952_CR246","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT05156229 (2022)."},{"key":"952_CR247","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT04592484 (2023)."},{"key":"952_CR248","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63718-2","volume":"16","author":"VS Kalluri","year":"2025","unstructured":"Kalluri, V. S. et al. Engineered exosomes with KrasG12D specific siRNA in pancreatic cancer: a phase I study with immunological correlates. Nat. Commun. 16, 8696 (2025). This phase I trial of engineered human bone marrow MSC-derived EVPs targeting mutant KRAS demonstrated safety in patients, and preclinical studies showed enhanced efficacy when combined with ICB, highlighting a promising therapeutic application of EVPs in combinatorial strategies.","journal-title":"Nat. Commun."},{"key":"952_CR249","doi-asserted-by":"publisher","first-page":"4920","DOI":"10.1158\/0008-5472.CAN-12-0925","volume":"72","author":"A Bobrie","year":"2012","unstructured":"Bobrie, A. et al. Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression. Cancer Res. 72, 4920\u20134930 (2012).","journal-title":"Cancer Res."},{"key":"952_CR250","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41568-019-0209-6","volume":"19","author":"Y Shaked","year":"2019","unstructured":"Shaked, Y. The pro-tumorigenic host response to cancer therapies. Nat. Rev. Cancer 19, 667\u2013685 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"952_CR251","doi-asserted-by":"publisher","first-page":"112503","DOI":"10.1016\/j.biopha.2021.112503","volume":"146","author":"J Zeien","year":"2022","unstructured":"Zeien, J. et al. Clinical implications of chemotherapeutic agent organ toxicity on perioperative care. Biomed. Pharmacother. 146, 112503 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"952_CR252","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1007\/s00210-023-02781-2","volume":"397","author":"A Sharma","year":"2024","unstructured":"Sharma, A., Jasrotia, S. & Kumar, A. Effects of chemotherapy on the immune system: implications for cancer treatment and patient outcomes. Naunyn Schmiedebergs Arch. Pharmacol. 397, 2551\u20132566 (2024).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"952_CR253","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41391-021-00456-8","volume":"25","author":"E Margolis","year":"2022","unstructured":"Margolis, E. et al. Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies. Prostate Cancer Prostatic Dis. 25, 296\u2013301 (2022).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"952_CR254","doi-asserted-by":"publisher","first-page":"eabm3453","DOI":"10.1126\/sciadv.abm3453","volume":"8","author":"S Ferguson","year":"2022","unstructured":"Ferguson, S. et al. Single-EV analysis (sEVA) of mutated proteins allows detection of stage 1 pancreatic cancer. Sci. Adv. 8, eabm3453 (2022).","journal-title":"Sci. Adv."},{"key":"952_CR255","doi-asserted-by":"publisher","first-page":"0041","DOI":"10.34133\/research.0041","volume":"6","author":"W Guo","year":"2023","unstructured":"Guo, W. et al. Single-exosome profiling identifies ITGB3+ and ITGAM+ exosome subpopulations as promising early diagnostic biomarkers and therapeutic targets for colorectal cancer. Research 6, 0041 (2023).","journal-title":"Research"},{"key":"952_CR256","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jare.2024.08.026","volume":"73","author":"H Lin","year":"2025","unstructured":"Lin, H. et al. Simultaneous detection of membrane protein and mRNA at single extracellular vesicle level by droplet microfluidics for cancer diagnosis. J. Adv. Res. 73, 645\u2013657 (2025).","journal-title":"J. Adv. Res."},{"key":"952_CR257","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1136\/gutjnl-2021-324109","volume":"71","author":"LI Ruffolo","year":"2022","unstructured":"Ruffolo, L. I. et al. GM-CSF drives myelopoiesis, recruitment and polarisation of tumour-associated macrophages in cholangiocarcinoma and systemic blockade facilitates antitumour immunity. Gut 71, 1386\u20131398 (2022).","journal-title":"Gut"},{"key":"952_CR258","doi-asserted-by":"publisher","first-page":"E566","DOI":"10.1073\/pnas.1424927112","volume":"112","author":"AJ Casbon","year":"2015","unstructured":"Casbon, A. J. et al. Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils. Proc. Natl Acad. Sci. USA 112, E566\u2013E575 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"952_CR259","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1158\/0008-5472.CAN-17-3026","volume":"79","author":"MF Al Sayed","year":"2019","unstructured":"Al Sayed, M. F. et al. T-cell-secreted TNF\u03b1 induces emergency myelopoiesis and myeloid-derived suppressor cell differentiation in cancer. Cancer Res. 79, 346\u2013359 (2019).","journal-title":"Cancer Res."},{"key":"952_CR260","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002856","volume":"9","author":"K Magidey-Klein","year":"2021","unstructured":"Magidey-Klein, K. et al. IL-6 contributes to metastatic switch via the differentiation of monocytic-dendritic progenitors into prometastatic immune cells. J. Immunother. Cancer 9, e002856\u00a0(2021).","journal-title":"J. Immunother. Cancer"},{"key":"952_CR261","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1111\/cas.13809","volume":"109","author":"H Shi","year":"2018","unstructured":"Shi, H. et al. Chemokine (C-X-C motif) ligand 1 and CXCL2 produced by tumor promote the generation of monocytic myeloid-derived suppressor cells. Cancer Sci. 109, 3826\u20133839 (2018).","journal-title":"Cancer Sci."},{"key":"952_CR262","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s13046-024-03138-0","volume":"43","author":"A Giammona","year":"2024","unstructured":"Giammona, A. et al. Tumor-derived GLI1 promotes remodeling of the immune tumor microenvironment in melanoma. J. Exp. Clin. Cancer Res. 43, 214 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"952_CR263","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1158\/0008-5472.CAN-23-0046","volume":"83","author":"DK Nambiar","year":"2023","unstructured":"Nambiar, D. K. et al. Galectin-1 mediates chronic STING activation in tumors to promote metastasis through MDSC recruitment. Cancer Res. 83, 3205\u20133219 (2023).","journal-title":"Cancer Res."},{"key":"952_CR264","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1053\/j.gastro.2023.04.032","volume":"165","author":"J Zhai","year":"2023","unstructured":"Zhai, J. et al. ALKBH5 drives immune suppression via targeting AXIN2 to promote colorectal cancer and is a target for boosting immunotherapy. Gastroenterology 165, 445\u2013462 (2023).","journal-title":"Gastroenterology"},{"key":"952_CR265","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.immuni.2025.04.027","volume":"58","author":"AG Blidner","year":"2025","unstructured":"Blidner, A. G. et al. Glycosylation-driven programs coordinate immunoregulatory and pro-angiogenic functions of myeloid-derived suppressor cells. Immunity 58, 1553\u20131571.e8 (2025).","journal-title":"Immunity"},{"key":"952_CR266","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.cmet.2024.01.005","volume":"36","author":"C Hu","year":"2024","unstructured":"Hu, C. et al. Tumor-secreted FGF21 acts as an immune suppressor by rewiring cholesterol metabolism of CD8+ T cells. Cell Metab. 36, 630\u2013647.e8 (2024).","journal-title":"Cell Metab."},{"key":"952_CR267","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1016\/j.immuni.2023.11.002","volume":"56","author":"T Taifour","year":"2023","unstructured":"Taifour, T. et al. The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancer. Immunity 56, 2755\u20132772.e8 (2023).","journal-title":"Immunity"},{"key":"952_CR268","doi-asserted-by":"publisher","first-page":"eadr3026","DOI":"10.1126\/science.adr3026","volume":"388","author":"DK Chiu","year":"2025","unstructured":"Chiu, D. K. et al. Tumor-derived erythropoietin acts as an immunosuppressive switch in cancer immunity. Science 388, eadr3026 (2025).","journal-title":"Science"},{"key":"952_CR269","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1158\/1078-0432.CCR-22-1366","volume":"29","author":"SA Patel","year":"2023","unstructured":"Patel, S. A. et al. Molecular mechanisms and future implications of VEGF\/VEGFR in cancer therapy. Clin. Cancer Res. 29, 30\u201339 (2023).","journal-title":"Clin. Cancer Res."},{"key":"952_CR270","doi-asserted-by":"publisher","first-page":"107347","DOI":"10.1016\/j.jbc.2024.107347","volume":"300","author":"ES Radisky","year":"2024","unstructured":"Radisky, E. S. Extracellular proteolysis in cancer: proteases, substrates, and mechanisms in tumor progression and metastasis. J. Biol. Chem. 300, 107347 (2024).","journal-title":"J. Biol. Chem."},{"key":"952_CR271","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/nrc2228","volume":"7","author":"C Lopez-Otin","year":"2007","unstructured":"Lopez-Otin, C. & Matrisian, L. M. Emerging roles of proteases in tumour suppression. Nat. Rev. Cancer 7, 800\u2013808 (2007).","journal-title":"Nat. Rev. Cancer"},{"key":"952_CR272","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1172\/JCI33775","volume":"118","author":"HA Kenny","year":"2008","unstructured":"Kenny, H. A., Kaur, S., Coussens, L. M. & Lengyel, E. The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J. Clin. Invest. 118, 1367\u20131379 (2008).","journal-title":"J. Clin. Invest."},{"key":"952_CR273","doi-asserted-by":"publisher","first-page":"eaao4227","DOI":"10.1126\/science.aao4227","volume":"361","author":"J Albrengues","year":"2018","unstructured":"Albrengues, J. et al. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science 361, eaao4227 (2018).","journal-title":"Science"},{"key":"952_CR274","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.ccell.2022.08.012","volume":"40","author":"Q Shi","year":"2022","unstructured":"Shi, Q. et al. Increased glucose metabolism in TAMs fuels O-GlcNAcylation of lysosomal cathepsin B to promote cancer metastasis and chemoresistance. Cancer Cell 40, 1207\u20131222.e10 (2022).","journal-title":"Cancer Cell"},{"key":"952_CR275","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/ng1249","volume":"35","author":"M Balbin","year":"2003","unstructured":"Balbin, M. et al. Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat. Genet. 35, 252\u2013257 (2003).","journal-title":"Nat. Genet."},{"key":"952_CR276","doi-asserted-by":"publisher","first-page":"6149","DOI":"10.1158\/0008-5472.CAN-04-0297","volume":"66","author":"AM Houghton","year":"2006","unstructured":"Houghton, A. M. et al. Macrophage elastase (matrix metalloproteinase-12) suppresses growth of lung metastases. Cancer Res. 66, 6149\u20136155 (2006).","journal-title":"Cancer Res."},{"key":"952_CR277","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1126\/science.289.5488.2363","volume":"289","author":"DC Guttridge","year":"2000","unstructured":"Guttridge, D. C., Mayo, M. W., Madrid, L. V., Wang, C. Y. & Baldwin, A. S. Jr. NF-\u03baB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289, 2363\u20132366 (2000).","journal-title":"Science"},{"key":"952_CR278","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jmb.2008.08.087","volume":"384","author":"V Adams","year":"2008","unstructured":"Adams, V. et al. Induction of MuRF1 is essential for TNF-\u03b1-induced loss of muscle function in mice. J. Mol. Biol. 384, 48\u201359 (2008).","journal-title":"J. Mol. Biol."},{"key":"952_CR279","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1096\/fj.04-2364com","volume":"19","author":"YP Li","year":"2005","unstructured":"Li, Y. P. et al. TNF-\u03b1\u00a0acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1\/MAFbx in skeletal muscle. FASEB J. 19, 362\u2013370 (2005).","journal-title":"FASEB J."},{"key":"952_CR280","doi-asserted-by":"publisher","first-page":"eadm8857","DOI":"10.1126\/science.adm8857","volume":"388","author":"XA Zhu","year":"2025","unstructured":"Zhu, X. A. et al. A neuroimmune circuit mediates cancer cachexia-associated apathy. Science 388, eadm8857 (2025).","journal-title":"Science"},{"key":"952_CR281","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1038\/nm.4392","volume":"23","author":"SE Mullican","year":"2017","unstructured":"Mullican, S. E. et al. GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates. Nat. Med. 23, 1150\u20131157 (2017).","journal-title":"Nat. Med."},{"key":"952_CR282","doi-asserted-by":"publisher","first-page":"111947","DOI":"10.1016\/j.celrep.2022.111947","volume":"42","author":"JY Kim-Muller","year":"2023","unstructured":"Kim-Muller, J. Y. et al. GDF15 neutralization restores muscle function and physical performance in a mouse model of cancer cachexia. Cell Rep. 42, 111947 (2023).","journal-title":"Cell Rep."},{"key":"952_CR283","doi-asserted-by":"publisher","first-page":"103166","DOI":"10.1016\/j.critrevonc.2020.103166","volume":"157","author":"Z Hu","year":"2021","unstructured":"Hu, Z., Chen, H., Long, Y., Li, P. & Gu, Y. The main sources of circulating cell-free DNA: apoptosis, necrosis and active secretion. Crit. Rev. Oncol. Hematol. 157, 103166 (2021).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"952_CR284","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41568-025-00795-x","volume":"25","author":"DC Bruhm","year":"2025","unstructured":"Bruhm, D. C. et al. Genomic and fragmentomic landscapes of cell-free DNA for early cancer detection. Nat. Rev. Cancer 25, 341\u2013358 (2025).","journal-title":"Nat. Rev. Cancer"},{"key":"952_CR285","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1200\/JCO.24.00287","volume":"43","author":"L Yin","year":"2025","unstructured":"Yin, L. et al. Development and validation of a cell-free DNA fragmentomics-based model for early detection of pancreatic cancer. J. Clin. Oncol. 43, 2863-2874\u00a0(2025).","journal-title":"J. Clin. Oncol."},{"key":"952_CR286","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1001\/jama.2025.7515","volume":"334","author":"A Shaukat","year":"2025","unstructured":"Shaukat, A. et al. Clinical validation of a circulating tumor DNA-based blood test to screen for colorectal cancer. JAMA 334, 56\u201363 (2025).","journal-title":"JAMA"},{"key":"952_CR287","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1158\/2159-8290.CD-24-0393","volume":"15","author":"JE Medina","year":"2025","unstructured":"Medina, J. E. et al. Early detection of ovarian cancer using cell-free DNA fragmentomes and protein biomarkers. Cancer Discov. 15, 105\u2013118 (2025).","journal-title":"Cancer Discov."},{"key":"952_CR288","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1158\/1078-0432.CCR-24-0924","volume":"31","author":"M Ghidini","year":"2025","unstructured":"Ghidini, M. et al. Circulating tumor DNA dynamics and clinical outcome in metastatic colorectal cancer patients undergoing front-line chemotherapy. Clin. Cancer Res. 31, 707\u2013718 (2025).","journal-title":"Clin. Cancer Res."},{"key":"952_CR289","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1038\/s41591-025-03579-w","volume":"31","author":"J Tie","year":"2025","unstructured":"Tie, J. et al. Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial. Nat. Med. 31, 1509\u20131518 (2025).","journal-title":"Nat. Med."},{"key":"952_CR290","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/s43018-025-00960-z","volume":"6","author":"J Martin-Arana","year":"2025","unstructured":"Martin-Arana, J. et al. Whole-exome tumor-agnostic ctDNA analysis enhances minimal residual disease detection and reveals relapse mechanisms in localized colon cancer. Nat. Cancer 6, 1000\u20131016 (2025).","journal-title":"Nat. Cancer"},{"key":"952_CR291","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1093\/annonc\/mdu239","volume":"25","author":"L De Mattos-Arruda","year":"2014","unstructured":"De Mattos-Arruda, L. et al. Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle. Ann. Oncol. 25, 1729\u20131735 (2014).","journal-title":"Ann. Oncol."},{"key":"952_CR292","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47195-7","volume":"15","author":"AM Conway","year":"2024","unstructured":"Conway, A. M. et al. A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary. Nat. Commun. 15, 3292 (2024).","journal-title":"Nat. Commun."},{"key":"952_CR293","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1200\/JCO.2005.03.7598","volume":"24","author":"Y Li","year":"2006","unstructured":"Li, Y. et al. Serum circulating human mRNA profiling and its utility for oral cancer detection. J. Clin. Oncol. 24, 1754\u20131760 (2006).","journal-title":"J. Clin. Oncol."},{"key":"952_CR294","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41586-025-08834-1","volume":"641","author":"MC Nesselbush","year":"2025","unstructured":"Nesselbush, M. C. et al. An ultrasensitive method for detection of cell-free RNA. Nature 641, 759\u2013768 (2025).","journal-title":"Nature"},{"key":"952_CR295","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3390\/cimb47070508","volume":"47","author":"CM Kan","year":"2025","unstructured":"Kan, C. M. et al. Validation of prognostic circulating cell-free RNA biomarkers HPGD, PACS1, and TDP2 in colorectal cancer through TaqMan qPCR and correlation analysis. Curr. Issues Mol. Biol. 47, 508\u00a0(2025).","journal-title":"Curr. Issues Mol. Biol."},{"key":"952_CR296","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/s41587-025-02731-8","volume":"44","author":"CW Ju","year":"2026","unstructured":"Ju, C. W. et al. Modifications of microbiome-derived cell-free RNA in plasma discriminates colorectal cancer samples. Nat. Biotechnol. 44, 752\u2013758 (2026).","journal-title":"Nat. Biotechnol."},{"key":"952_CR297","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.75181","volume":"11","author":"S Chen","year":"2022","unstructured":"Chen, S. et al. Cancer type classification using plasma cell-free RNAs derived from human and microbes. eLife 11, e75181 (2022).","journal-title":"eLife"},{"key":"952_CR298","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.eururo.2020.03.044","volume":"78","author":"H Fettke","year":"2020","unstructured":"Fettke, H. et al. Combined cell-free DNA and RNA profiling of the androgen receptor: clinical utility of a novel multianalyte liquid biopsy assay for metastatic prostate cancer. Eur. Urol. 78, 173\u2013180 (2020).","journal-title":"Eur. Urol."},{"key":"952_CR299","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1090","volume":"12","author":"LJ Albrecht","year":"2022","unstructured":"Albrecht, L. J. et al. Circulating cell-free messenger RNA enables non-invasive pan-tumour monitoring of melanoma therapy independent of the mutational genotype. Clin. Transl. Med. 12, e1090 (2022).","journal-title":"Clin. Transl. Med."},{"key":"952_CR300","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","volume":"30","author":"X Ma","year":"2019","unstructured":"Ma, X. et al. Cholesterol induces CD8+ T cell exhaustion in the tumor microenvironment. Cell Metab. 30, 143\u2013156.e5 (2019).","journal-title":"Cell Metab."},{"key":"952_CR301","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00910-z","volume":"8","author":"AE Baek","year":"2017","unstructured":"Baek, A. E. et al. The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells. Nat. Commun. 8, 864 (2017).","journal-title":"Nat. Commun."},{"key":"952_CR302","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50138-x","volume":"15","author":"X Zhou","year":"2024","unstructured":"Zhou, X. et al. Inhibition of DUSP18 impairs cholesterol biosynthesis and promotes anti-tumor immunity in colorectal cancer. Nat. Commun. 15, 5851 (2024).","journal-title":"Nat. Commun."},{"key":"952_CR303","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.immuni.2023.05.011","volume":"56","author":"F Bayerl","year":"2023","unstructured":"Bayerl, F. et al. Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses. Immunity 56, 1341\u20131358.e11 (2023).","journal-title":"Immunity"},{"key":"952_CR304","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","volume":"24","author":"A Brand","year":"2016","unstructured":"Brand, A. et al. LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab. 24, 657\u2013671 (2016).","journal-title":"Cell Metab."},{"key":"952_CR305","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","volume":"591","author":"MJ Watson","year":"2021","unstructured":"Watson, M. J. et al. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature 591, 645\u2013651 (2021).","journal-title":"Nature"},{"key":"952_CR306","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24384-2","volume":"12","author":"M Mathieu","year":"2021","unstructured":"Mathieu, M. et al. Specificities of exosome versus small ectosome secretion revealed by live intracellular tracking of CD63 and CD9. Nat. Commun. 12, 4389 (2021).","journal-title":"Nat. Commun."},{"key":"952_CR307","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/s41556-022-00934-8","volume":"24","author":"SB Arya","year":"2022","unstructured":"Arya, S. B., Chen, S., Jordan-Javed, F. & Parent, C. A. Ceramide-rich microdomains facilitate nuclear envelope budding for non-conventional exosome formation. Nat. Cell Biol. 24, 1019\u20131028 (2022).","journal-title":"Nat. Cell Biol."},{"key":"952_CR308","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh, J. A. et al. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J. Extracell. Vesicles 13, e12404 (2024).","journal-title":"J. Extracell. Vesicles"},{"key":"952_CR309","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41556-018-0040-4","volume":"20","author":"H Zhang","year":"2018","unstructured":"Zhang, H. et al. Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation. Nat. Cell Biol. 20, 332\u2013343 (2018).","journal-title":"Nat. Cell Biol."},{"key":"952_CR310","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/s41556-021-00805-8","volume":"23","author":"Q Zhang","year":"2021","unstructured":"Zhang, Q. et al. Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets. Nat. Cell Biol. 23, 1240\u20131254 (2021).","journal-title":"Nat. Cell Biol."},{"key":"952_CR311","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41573-022-00410-w","volume":"21","author":"L Cheng","year":"2022","unstructured":"Cheng, L. & Hill, A. F. Therapeutically harnessing extracellular vesicles. Nat. Rev. Drug Discov. 21, 379\u2013399 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"952_CR312","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.semcdb.2015.02.010","volume":"40","author":"VR Minciacchi","year":"2015","unstructured":"Minciacchi, V. R., Freeman, M. R. & Di Vizio, D. Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes. Semin. Cell Dev. Biol. 40, 41\u201351 (2015).","journal-title":"Semin. Cell Dev. Biol."},{"key":"952_CR313","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.tcb.2024.05.003","volume":"35","author":"D Jiang","year":"2025","unstructured":"Jiang, D., He, J. & Yu, L. The migrasome, an organelle for cell-cell communication. Trends Cell Biol. 35, 205-216\u00a0(2025).","journal-title":"Trends Cell Biol."},{"key":"952_CR314","doi-asserted-by":"publisher","DOI":"10.1002\/bies.202300182","volume":"46","author":"KC Sule","year":"2024","unstructured":"Sule, K. C., Nakamura, M. & Parkhurst, S. M. Nuclear envelope budding: getting large macromolecular complexes out of the nucleus. Bioessays 46, e2300182 (2024).","journal-title":"Bioessays"},{"key":"952_CR315","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41580-023-00576-0","volume":"24","author":"AC Dixson","year":"2023","unstructured":"Dixson, A. C., Dawson, T. R., Di Vizio, D. & Weaver, A. M. Context-specific regulation of extracellular vesicle biogenesis and cargo selection. Nat. Rev. Mol. Cell Biol. 24, 454\u2013476 (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"952_CR316","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.tcb.2023.01.002","volume":"33","author":"DK Jeppesen","year":"2023","unstructured":"Jeppesen, D. K., Zhang, Q., Franklin, J. L. & Coffey, R. J. Extracellular vesicles and nanoparticles: emerging complexities. Trends Cell Biol. 33, 667\u2013681 (2023).","journal-title":"Trends Cell Biol."},{"key":"952_CR317","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41556-018-0250-9","volume":"21","author":"M Mathieu","year":"2019","unstructured":"Mathieu, M., Martin-Jaular, L., Lavieu, G. & Thery, C. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat. Cell Biol. 21, 9\u201317 (2019).","journal-title":"Nat. Cell Biol."},{"key":"952_CR318","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1074\/mcp.RA118.000644","volume":"17","author":"D Choi","year":"2018","unstructured":"Choi, D. et al. The impact of oncogenic EGFRvIII on the proteome of extracellular vesicles released from glioblastoma cells. Mol. Cell Proteom. 17, 1948\u20131964 (2018).","journal-title":"Mol. Cell Proteom."},{"key":"952_CR319","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12091","volume":"10","author":"D Choi","year":"2021","unstructured":"Choi, D. et al. Oncogenic RAS drives the CRAF-dependent extracellular vesicle uptake mechanism coupled with metastasis. J. Extracell. Vesicles 10, e12091 (2021).","journal-title":"J. Extracell. Vesicles"},{"key":"952_CR320","doi-asserted-by":"publisher","first-page":"1490144","DOI":"10.1080\/20013078.2018.1490144","volume":"7","author":"C Spinelli","year":"2018","unstructured":"Spinelli, C. et al. Molecular subtypes and differentiation programmes of glioma stem cells as determinants of extracellular vesicle profiles and endothelial cell-stimulating activities. J. Extracell. Vesicles 7, 1490144 (2018).","journal-title":"J. Extracell. Vesicles"},{"key":"952_CR321","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1158\/0008-5472.CAN-09-1915","volume":"70","author":"Y Min","year":"2010","unstructured":"Min, Y. et al. Tie2 signaling regulates osteoclastogenesis and osteolytic bone invasion of breast cancer. Cancer Res. 70, 2819\u20132828 (2010).","journal-title":"Cancer Res."},{"key":"952_CR322","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1084\/jem.20190158","volume":"216","author":"J Dai","year":"2019","unstructured":"Dai, J. et al. Primary prostate cancer educates bone stroma through exosomal pyruvate kinase M2 to promote bone metastasis. J. Exp. Med. 216, 2883\u20132899 (2019).","journal-title":"J. Exp. Med."},{"key":"952_CR323","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068171","volume":"8","author":"AC Monteiro","year":"2013","unstructured":"Monteiro, A. C. et al. T cells induce pre-metastatic osteolytic disease and help bone metastases establishment in a mouse model of metastatic breast cancer. PLoS ONE 8, e68171 (2013).","journal-title":"PLoS ONE"},{"key":"952_CR324","doi-asserted-by":"publisher","first-page":"567844","DOI":"10.3389\/fendo.2020.567844","volume":"11","author":"MA Riquelme","year":"2020","unstructured":"Riquelme, M. A., Cardenas, E. R. & Jiang, J. X. Osteocytes and bone metastasis. Front. Endocrinol. 11, 567844 (2020).","journal-title":"Front. Endocrinol."},{"key":"952_CR325","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/s43018-021-00272-y","volume":"2","author":"S Garcia-Silva","year":"2021","unstructured":"Garcia-Silva, S. et al. Melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR-dependent mechanism. Nat. Cancer 2, 1387\u20131405 (2021).","journal-title":"Nat. Cancer"},{"key":"952_CR326","doi-asserted-by":"publisher","DOI":"10.1172\/JCI146431","volume":"131","author":"C Chen","year":"2021","unstructured":"Chen, C. et al. SUMOylation promotes extracellular vesicle-mediated transmission of lncRNA ELNAT1 and lymph node metastasis in bladder cancer. J. Clin. Invest. 131, e146431\u00a0(2021).","journal-title":"J. Clin. Invest."},{"key":"952_CR327","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10456-019-09693-x","volume":"23","author":"P Garcia-Gomez","year":"2020","unstructured":"Garcia-Gomez, P. & Valiente, M. Vascular co-option in brain metastasis. Angiogenesis 23, 3\u20138 (2020).","journal-title":"Angiogenesis"},{"key":"952_CR328","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature15376","volume":"527","author":"L Zhang","year":"2015","unstructured":"Zhang, L. et al. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature 527, 100\u2013104 (2015). This work uncovers the microenvironment-dependent modulation of tumour cells by astrocyte-derived EVPs in the brain, highlighting the reciprocal co-evolution between tumour cells and their metastatic niche, and providing new therapeutic strategies for brain metastasis.","journal-title":"Nature"},{"key":"952_CR329","doi-asserted-by":"publisher","first-page":"121314","DOI":"10.1016\/j.biomaterials.2021.121314","volume":"280","author":"R Koide","year":"2022","unstructured":"Koide, R. et al. Antiadhesive nanosome elicits role of glycocalyx of tumor cell-derived exosomes in the organotropic cancer metastasis. Biomaterials 280, 121314 (2022).","journal-title":"Biomaterials"},{"key":"952_CR330","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1023\/B:GLYC.0000043741.47559.30","volume":"21","author":"J Gu","year":"2004","unstructured":"Gu, J. & Taniguchi, N. Regulation of integrin functions by N-glycans. Glycoconj. J. 21, 9\u201315 (2004).","journal-title":"Glycoconj. J."},{"key":"952_CR331","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1165\/ajrcmb.23.6.4202","volume":"23","author":"RA Pierce","year":"2000","unstructured":"Pierce, R. A., Griffin, G. L., Miner, J. H. & Senior, R. M. Expression patterns of laminin alpha1 and alpha5 in human lung during development. Am. J. Respir. Cell Mol. Biol. 23, 742\u2013747 (2000).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"952_CR332","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.3390\/ijms22041770","volume":"22","author":"L Cao","year":"2021","unstructured":"Cao, L. et al. Role of site-specific glycosylation in the I-like domain of integrin beta1 in small extracellular vesicle-mediated malignant behavior and FAK activation. Int. J. Mol. Sci. 22, 1770\u00a0(2021).","journal-title":"Int. J. Mol. Sci."},{"key":"952_CR333","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.it.2013.03.001","volume":"34","author":"JJ Garcia-Vallejo","year":"2013","unstructured":"Garcia-Vallejo, J. J. & van Kooyk, Y. The physiological role of DC-SIGN: a tale of mice and men. Trends Immunol. 34, 482\u2013486 (2013).","journal-title":"Trends Immunol."},{"key":"952_CR334","doi-asserted-by":"publisher","first-page":"14097","DOI":"10.1073\/pnas.1617903113","volume":"113","author":"Y Kimura","year":"2016","unstructured":"Kimura, Y. et al. The innate immune receptor Dectin-2 mediates the phagocytosis of cancer cells by Kupffer cells for the suppression of liver metastasis. Proc. Natl Acad. Sci. USA 113, 14097\u201314102 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"952_CR335","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29780-1","volume":"8","author":"S Manca","year":"2018","unstructured":"Manca, S. et al. Milk exosomes are bioavailable and distinct microRNA cargos have unique tissue distribution patterns. Sci. Rep. 8, 11321 (2018).","journal-title":"Sci. Rep."},{"key":"952_CR336","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.chom.2018.10.001","volume":"24","author":"Y Teng","year":"2018","unstructured":"Teng, Y. et al. Plant-derived exosomal microRNAs shape the gut microbiota. Cell Host Microbe 24, 637\u2013652.e8 (2018).","journal-title":"Cell Host Microbe"},{"key":"952_CR337","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.3390\/antiox12101862","volume":"12","author":"J Yeo","year":"2023","unstructured":"Yeo, J. Food-derived extracellular vesicles as multi-bioactive complex and their versatile health effects. Antioxidants 12, 1862\u00a0(2023).","journal-title":"Antioxidants"},{"key":"952_CR338","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1002\/mnfr.201300729","volume":"58","author":"JY Mu","year":"2014","unstructured":"Mu, J. Y. et al. Interspecies communication between plant and mouse gut host cells through edible plant derived exosome-like nanoparticles. Mol. Nutr. Food Res. 58, 1561\u20131573 (2014).","journal-title":"Mol. Nutr. Food Res."},{"key":"952_CR339","doi-asserted-by":"publisher","first-page":"747294","DOI":"10.3389\/fnut.2021.747294","volume":"8","author":"X Feng","year":"2021","unstructured":"Feng, X. et al. Latest trend of milk derived exosomes: cargos, functions, and applications. Front. Nutr. 8, 747294 (2021).","journal-title":"Front. Nutr."},{"key":"952_CR340","doi-asserted-by":"publisher","first-page":"1009338","DOI":"10.3389\/fgene.2022.1009338","volume":"13","author":"M Rashidi","year":"2022","unstructured":"Rashidi, M., Bijari, S., Khazaei, A. H., Shojaei-Ghahrizjani, F. & Rezakhani, L. The role of milk-derived exosomes in the treatment of diseases. Front. Genet. 13, 1009338 (2022).","journal-title":"Front. Genet."},{"key":"952_CR341","doi-asserted-by":"publisher","first-page":"1215650","DOI":"10.3389\/fbioe.2023.1215650","volume":"11","author":"IM Sall","year":"2023","unstructured":"Sall, I. M. & Flaviu, T. A. Plant and mammalian-derived extracellular vesicles: a new therapeutic approach for the future. Front. Bioeng. Biotechnol. 11, 1215650 (2023).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"952_CR342","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41591-019-0377-7","volume":"25","author":"BA Helmink","year":"2019","unstructured":"Helmink, B. A., Khan, M. A. W., Hermann, A., Gopalakrishnan, V. & Wargo, J. A. The microbiome, cancer, and cancer therapy. Nat. Med. 25, 377\u2013388 (2019).","journal-title":"Nat. Med."},{"key":"952_CR343","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.ccell.2021.08.006","volume":"39","author":"N Cullin","year":"2021","unstructured":"Cullin, N., Azevedo Antunes, C., Straussman, R., Stein-Thoeringer, C. K. & Elinav, E. Microbiome and cancer. Cancer Cell 39, 1317\u20131341 (2021).","journal-title":"Cancer Cell"},{"key":"952_CR344","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.chom.2025.06.013","volume":"33","author":"H Yu","year":"2025","unstructured":"Yu, H. et al. Lactate production by tumor-resident Staphylococcus promotes metastatic colonization in lung adenocarcinoma. Cell Host Microbe 33, 1089\u20131105.e7 (2025).","journal-title":"Cell Host Microbe"},{"key":"952_CR345","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.12.040","volume":"176","author":"C Jin","year":"2019","unstructured":"Jin, C. et al. Commensal microbiota promote lung cancer development via \u03b3\u03b4 T cells. Cell 176, 998\u20131013.e16 (2019).","journal-title":"Cell"},{"key":"952_CR346","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan, V. et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359, 97\u2013103 (2018).","journal-title":"Science"},{"key":"952_CR347","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy, B. et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359, 91\u201397 (2018).","journal-title":"Science"},{"key":"952_CR348","doi-asserted-by":"publisher","first-page":"101753","DOI":"10.1016\/j.xcrm.2024.101753","volume":"5","author":"S Guo","year":"2024","unstructured":"Guo, S. et al. Leucine restriction ameliorates Fusobacterium nucleatum-driven malignant progression and radioresistance in nasopharyngeal carcinoma. Cell Rep. Med. 5, 101753 (2024).","journal-title":"Cell Rep. Med."},{"key":"952_CR349","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.cell.2017.07.008","volume":"170","author":"T Yu","year":"2017","unstructured":"Yu, T. et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell 170, 548\u2013563.e16 (2017).","journal-title":"Cell"},{"key":"952_CR350","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202207366","volume":"10","author":"Q Yang","year":"2023","unstructured":"Yang, Q. et al. A review of gut microbiota-derived metabolites in tumor progression and cancer therapy. Adv. Sci. 10, e2207366 (2023).","journal-title":"Adv. Sci."},{"key":"952_CR351","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41568-023-00594-2","volume":"23","author":"G El Tekle","year":"2023","unstructured":"El Tekle, G. & Garrett, W. S. Bacteria in cancer initiation, promotion and progression. Nat. Rev. Cancer 23, 600\u2013618 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"952_CR352","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10844-z","volume":"23","author":"G Li","year":"2023","unstructured":"Li, G. et al. Fusobacterium nucleatum-derived small extracellular vesicles facilitate tumor growth and metastasis via TLR4 in breast cancer. BMC Cancer 23, 473 (2023).","journal-title":"BMC Cancer"},{"key":"952_CR353","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jare.2023.04.002","volume":"56","author":"G Chen","year":"2024","unstructured":"Chen, G. et al. Fusobacterium nucleatum outer membrane vesicles activate autophagy to promote oral cancer metastasis. J. Adv. Res. 56, 167\u2013179 (2024).","journal-title":"J. Adv. Res."},{"key":"952_CR354","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.47","volume":"49","author":"HI Choi","year":"2017","unstructured":"Choi, H. I. et al. Helicobacter pylori-derived extracellular vesicles increased in the gastric juices of gastric adenocarcinoma patients and induced inflammation mainly via specific targeting of gastric epithelial cells. Exp. Mol. Med. 49, e330 (2017).","journal-title":"Exp. Mol. Med."},{"key":"952_CR355","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1111\/cas.16202","volume":"115","author":"K Jingushi","year":"2024","unstructured":"Jingushi, K. et al. Cutibacterium acnes-derived extracellular vesicles promote tumor growth in renal cell carcinoma. Cancer Sci. 115, 2578\u20132587\u00a0(2024).","journal-title":"Cancer Sci."},{"key":"952_CR356","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12357","volume":"12","author":"S Won","year":"2023","unstructured":"Won, S. et al. Mass-produced Gram-negative bacterial outer membrane vesicles activate cancer antigen-specific stem-like CD8+ T cells which enables an effective combination immunotherapy with anti-PD-1. J. Extracell. Vesicles 12, e12357 (2023).","journal-title":"J. Extracell. Vesicles"},{"key":"952_CR357","doi-asserted-by":"publisher","first-page":"103665","DOI":"10.1016\/j.esmoop.2024.103665","volume":"9","author":"O Garrone","year":"2024","unstructured":"Garrone, O. et al. Moderate physical activity during neoadjuvant chemotherapy in breast cancer patients: effect on cancer-related inflammation and pathological complete response-the Neo-Runner study. ESMO Open 9, 103665 (2024).","journal-title":"ESMO Open"},{"key":"952_CR358","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s42255-021-00402-x","volume":"3","author":"H Zhang","year":"2021","unstructured":"Zhang, H. et al. Pre-operative exercise therapy triggers anti-inflammatory trained immunity of Kupffer cells through metabolic reprogramming. Nat. Metab. 3, 843\u2013858 (2021).","journal-title":"Nat. Metab."},{"key":"952_CR359","doi-asserted-by":"publisher","first-page":"4164","DOI":"10.1158\/0008-5472.CAN-22-0237","volume":"82","author":"D Sheinboim","year":"2022","unstructured":"Sheinboim, D. et al. An exercise-induced metabolic shield in distant organs blocks cancer progression and metastatic dissemination. Cancer Res. 82, 4164\u20134178 (2022).","journal-title":"Cancer Res."},{"key":"952_CR360","doi-asserted-by":"publisher","first-page":"28239","DOI":"10.3402\/jev.v4.28239","volume":"4","author":"C Fruhbeis","year":"2015","unstructured":"Fruhbeis, C., Helmig, S., Tug, S., Simon, P. & Kramer-Albers, E. M. Physical exercise induces rapid release of small extracellular vesicles into the circulation. J. Extracell. Vesicles 4, 28239 (2015).","journal-title":"J. Extracell. Vesicles"},{"key":"952_CR361","doi-asserted-by":"publisher","first-page":"952","DOI":"10.14336\/AD.2022.1131","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Exercise improves metabolism and alleviates atherosclerosis via muscle-derived extracellular vesicles. Aging Dis. 14, 952\u2013965 (2023).","journal-title":"Aging Dis."},{"key":"952_CR362","doi-asserted-by":"publisher","first-page":"1615820","DOI":"10.1080\/20013078.2019.1615820","volume":"8","author":"A Brahmer","year":"2019","unstructured":"Brahmer, A. et al. Platelets, endothelial cells and leukocytes contribute to the exercise-triggered release of extracellular vesicles into the circulation. J. Extracell. Vesicles 8, 1615820 (2019).","journal-title":"J. Extracell. Vesicles"},{"key":"952_CR363","doi-asserted-by":"publisher","first-page":"1054463","DOI":"10.3389\/fphys.2022.1054463","volume":"13","author":"JJ Vanhie","year":"2022","unstructured":"Vanhie, J. J. et al. The role of exercise-and high fat diet-induced bone marrow extracellular vesicles in stress hematopoiesis. Front. Physiol. 13, 1054463 (2022).","journal-title":"Front. Physiol."},{"key":"952_CR364","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1161\/CIRCRESAHA.121.320458","volume":"130","author":"H Zhao","year":"2022","unstructured":"Zhao, H. et al. Small extracellular vesicles from brown adipose tissue mediate exercise cardioprotection. Circ. Res. 130, 1490\u20131506 (2022).","journal-title":"Circ. Res."},{"key":"952_CR365","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jconrel.2015.12.018","volume":"222","author":"JS Choi","year":"2016","unstructured":"Choi, J. S. et al. Exosomes from differentiating human skeletal muscle cells trigger myogenesis of stem cells and provide biochemical cues for skeletal muscle regeneration. J. Control. Rel. 222, 107\u2013115 (2016).","journal-title":"J. Control. Rel."},{"key":"952_CR366","doi-asserted-by":"publisher","first-page":"30335","DOI":"10.1073\/pnas.2016112117","volume":"117","author":"C Castano","year":"2020","unstructured":"Castano, C., Mirasierra, M., Vallejo, M., Novials, A. & Parrizas, M. Delivery of muscle-derived exosomal miRNAs induced by HIIT improves insulin sensitivity through down-regulation of hepatic FoxO1 in mice. Proc. Natl Acad. Sci. USA 117, 30335\u201330343 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"952_CR367","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14310","volume":"23","author":"AC Rodrigues","year":"2024","unstructured":"Rodrigues, A. C., Heng, Y. J. & Slack, F. J. Extracellular vesicle-encapsulated miR-30c-5p reduces aging-related liver fibrosis. Aging Cell 23, e14310\u00a0(2024).","journal-title":"Aging Cell"},{"key":"952_CR368","doi-asserted-by":"publisher","first-page":"784080","DOI":"10.3389\/fmolb.2021.784080","volume":"8","author":"L Sadovska","year":"2021","unstructured":"Sadovska, L. et al. Exercise-induced extracellular vesicles delay the progression of prostate cancer. Front. Mol. Biosci. 8, 784080 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"952_CR369","doi-asserted-by":"publisher","first-page":"114697","DOI":"10.1016\/j.celrep.2024.114697","volume":"43","author":"Z Luo","year":"2024","unstructured":"Luo, Z. et al. Voluntary exercise sensitizes cancer immunotherapy via the collagen inhibition-orchestrated inflammatory tumor immune microenvironment. Cell Rep. 43, 114697 (2024).","journal-title":"Cell Rep."},{"key":"952_CR370","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45260-9","volume":"15","author":"S Brandhorst","year":"2024","unstructured":"Brandhorst, S. et al. Fasting-mimicking diet causes hepatic and blood markers changes indicating reduced biological age and disease risk. Nat. Commun. 15, 1309 (2024).","journal-title":"Nat. Commun."},{"key":"952_CR371","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/s42255-021-00469-6","volume":"3","author":"A Mishra","year":"2021","unstructured":"Mishra, A. et al. Fasting-mimicking diet prevents high-fat diet effect on cardiometabolic risk and lifespan. Nat. Metab. 3, 1342\u20131356 (2021).","journal-title":"Nat. Metab."},{"key":"952_CR372","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ccell.2016.05.016","volume":"30","author":"F Pietrocola","year":"2016","unstructured":"Pietrocola, F. et al. Caloric restriction mimetics enhance anticancer immunosurveillance. Cancer Cell 30, 147\u2013160 (2016).","journal-title":"Cancer Cell"},{"key":"952_CR373","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1056\/NEJMra1905136","volume":"381","author":"R de Cabo","year":"2019","unstructured":"de Cabo, R. & Mattson, M. P. Effects of intermittent fasting on health, aging, and disease. N. Engl. J. Med. 381, 2541\u20132551 (2019).","journal-title":"N. Engl. J. Med."},{"key":"952_CR374","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ccell.2016.06.005","volume":"30","author":"S Di Biase","year":"2016","unstructured":"Di Biase, S. et al. Fasting-mimicking diet reduces HO-1 to promote T cell-mediated tumor cytotoxicity. Cancer Cell 30, 136\u2013146 (2016).","journal-title":"Cancer Cell"},{"key":"952_CR375","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1111\/acel.12657","volume":"16","author":"E Eitan","year":"2017","unstructured":"Eitan, E. et al. In a randomized trial in prostate cancer patients, dietary protein restriction modifies markers of leptin and insulin signaling in plasma extracellular vesicles. Aging Cell 16, 1430\u20131433 (2017).","journal-title":"Aging Cell"},{"key":"952_CR376","doi-asserted-by":"publisher","first-page":"5701","DOI":"10.1016\/j.cell.2025.06.027","volume":"188","author":"CY Wu","year":"2025","unstructured":"Wu, C. Y. et al. Glucose restriction shapes pre-metastatic innate immune landscapes in the lung through exosomal TRAIL. Cell 188, 5701\u20135716.e19 (2025).","journal-title":"Cell"},{"key":"952_CR377","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s43586-023-00240-z","volume":"3","author":"A Hendrix","year":"2023","unstructured":"Hendrix, A. et al. Extracellular vesicle analysis. Nat. Rev. Methods Primers 3, 56\u00a0(2023).","journal-title":"Nat. Rev. Methods Primers"},{"key":"952_CR378","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12326","volume":"12","author":"L Blavier","year":"2023","unstructured":"Blavier, L. et al. The capture of extracellular vesicles endogenously released by xenotransplanted tumours induces an inflammatory reaction in the premetastatic niche. J. Extracell. Vesicles 12, e12326 (2023).","journal-title":"J. Extracell. Vesicles"},{"key":"952_CR379","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s44222-026-00405-x","volume":"4","author":"AP Chaudhari","year":"2026","unstructured":"Chaudhari, A. P. et al. The status of extracellular vesicles as drug carriers and therapeutics. Nat. Rev. Bioeng. 4, 301\u2013318\u00a0(2026).","journal-title":"Nat. Rev. Bioeng."}],"container-title":["Nature Reviews Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41568-026-00952-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41568-026-00952-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41568-026-00952-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:02:14Z","timestamp":1790164934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41568-026-00952-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":379,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["952"],"URL":"https:\/\/doi.org\/10.1038\/s41568-026-00952-w","relation":{},"ISSN":["1474-175X","1474-1768"],"issn-type":[{"value":"1474-175X","type":"print"},{"value":"1474-1768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"28 May 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.L. is on the scientific advisory board of Aufbau Holdings. D.L. receives research grant support from Aufbau\/Sonder Research X and Atossa Therapeutics. G.W., S.L., L.B., G.C.T., R.T.P., S.D. and H.Z. declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}